Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3045066	s-tymidk	U/l (u/l)	773	1154	0.17%
3045066	s-tymidk	U/l_______ (u/l)	228	708	0.00%
3045066	s-tymidk	— (—)	172	215	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Primary_lymphoid and hematopoietic malignant neoplasms

414

159

26.97

307.65

2.9

1.3

53.47

25.40

u/l

1.49

393

143

Enlarged lymph nodes

266

102

26.92

307.65

2.1

1.9

25.16

20.29

u/l

0.26

255

Liquid cancers, including Hilmo

495

199

22.48

307.65

2.7

1.3

55.02

25.01

u/l

2.03

472

177

Liquid cancers

474

164

28.20

307.65

2.8

1.3

56.99

25.44

u/l

1.87

452

147

Non-Hodgkin lymphoma, all, including Hilmo

272

41.87

307.65

3.2

1.4

46.93

37.75

u/l

0.16

255

Secondary uncertain malignant neoplasm

174

27.50

255.74

2.9

1.4

47.04

39.63

u/l

0.11

168

Secondary and unspecified malignant neoplasm of lymph nodes

159

36.88

255.18

3.0

1.6

46.62

47.49

u/l

0.01

154

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

180

22.22

244.29

2.9

1.4

42.53

32.88

u/l

0.20

174

Fever of other and unknown origin

325

338

8.39

233.02

2.0

1.9

51.39

31.39

u/l

1.01

300

303

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

459

571

5.45

200.22

1.9

41.57

34.64

u/l

0.33

428

507

Bacterial infection, other or unspecified

315

444

6.03

167.29

2.1

1.9

51.28

29.20

u/l

1.32

293

408

Bacterial infection, other or unspecified, including avohilmo

327

476

5.67

161.35

2.1

1.9

50.47

27.48

u/l

1.50

304

436

General symptoms and signs

362

357

5.10

128.97

1.8

1.9

44.91

30.40

u/l

0.64

330

318

Malignant neoplasm

316

348

5.34

127.13

2.1

1.3

37.33

22.28

u/l

0.88

292

302

Malignant neoplasm

316

348

5.34

127.12

2.1

1.3

37.33

22.28

u/l

0.88

292

302

Malignant neoplasm, including Hilmo

313

347

5.28

124.08

2.1

1.3

36.66

22.35

u/l

0.81

289

301

Malignant neoplasm, wide definition

312

351

5.20

121.80

2.1

1.3

36.74

22.29

u/l

0.83

288

305

Other bacterial diseases

369

616

3.98

112.30

2.0

1.9

57.23

26.58

u/l

2.13

337

562

Other diseases of blood and blood-forming organs, wide

161

227

7.19

107.99

2.4

1.8

66.96

32.21

u/l

1.09

156

209

Any event in cancer register

309

394

4.60

106.25

2.1

1.3

38.30

21.38

u/l

1.07

288

342

Other bacterial diseases, including avohilmo

363

604

3.76

100.43

2.0

1.9

53.47

26.69

u/l

1.74

330

547

First line medication for Crohn's disease

365

521

3.78

95.89

1.7

2.0

40.22

35.68

u/l

0.17

328

474

ILD medications: prednisolone, methylprednisolone, prednisone

367

551

3.71

95.43

1.8

2.0

42.66

34.26

u/l

0.36

332

502

ILD medications

371

553

3.63

92.32

1.7

2.0

41.55

34.23

u/l

0.31

334

504

Oral corticosteroids

362

613

3.47

87.61

1.9

35.21

39.07

u/l

0.16

334

553

Solid cancers

254

338

4.42

83.86

2.2

1.3

35.53

20.57

u/l

0.81

235

295

All pneumoniae

340

678

3.27

77.98

2.1

1.8

42.18

35.21

u/l

0.31

312

610

Pneumonias (Asthma/COPD co-morbidities)

337

676

3.26

77.36

2.0

1.8

42.50

34.80

u/l

0.35

309

608

Influenza and pneumonia

348

666

3.23

77.19

2.0

1.8

40.72

35.93

u/l

0.20

320

600

305

500

3.58

76.97

2.1

1.8

42.76

36.73

u/l

0.22

281

448

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

305

500

3.58

76.97

2.1

1.8

42.76

36.73

u/l

0.22

281

448

Solid cancers, including Hilmo

249

348

4.18

76.88

2.1

1.3

34.48

22.27

u/l

0.59

231

302

Inflammatory bowel disease treatment related agents

361

627

3.20

76.02

1.8

1.9

35.45

38.63

u/l

0.13

331

565

Malaise and fatigue

180

295

4.82

73.95

2.0

1.9

38.95

25.07

u/l

0.61

165

268

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

330

693

3.18

73.17

2.1

1.8

43.17

34.86

u/l

0.38

303

624

Pneumonia, organism unspecified

308

644

3.29

72.70

2.1

1.8

44.02

36.39

u/l

0.31

282

582

ILD medications: immunosuppressive drugs

216

499

3.93

72.13

1.7

2.0

23.78

35.79

u/l

0.99

188

454

Systemic connective tissue disorders

168

366

4.62

71.16

1.6

2.0

17.51

41.86

u/l

2.14

155

337

Other medical care

205

437

3.96

67.33

2.3

1.8

59.48

27.43

u/l

1.58

194

396

Certain disorders involving the immune mechanism

114

193

5.97

64.23

1.6

1.9

15.98

44.95

u/l

1.45

104

179

Neoplasms

191

221

4.54

62.15

1.8

1.2

34.91

23.44

u/l

0.53

181

191

GASTRO-related operations

194

217

4.50

61.10

1.7

1.6

38.64

36.33

u/l

0.05

182

199

Any gastric operation

194

217

4.50

61.10

1.7

1.6

38.64

36.33

u/l

0.05

182

199

Examination and observation for other reasons

203

301

3.82

55.38

2.0

1.4

32.96

33.49

u/l

0.02

190

272

Persons encountering health services for specific procedures and health care

310

656

2.79

53.46

2.0

1.8

51.80

27.90

u/l

1.31

284

593

Other systemic involvement of connective tissue (FG)

115

227

5.01

53.37

1.6

2.1

18.10

41.06

u/l

1.63

106

213

Medical observation and evaluation for suspected diseases and conditions

215

303

3.64

52.91

2.4

1.5

36.77

33.29

u/l

0.11

199

274

Certain infectious and parasitic diseases

258

426

3.04

48.55

1.8

1.9

41.10

30.56

u/l

0.41

236

386

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

232

707

2.86

46.70

2.1

1.9

29.85

42.33

u/l

0.66

211

648

Aplastic and other anaemias

179

506

3.25

45.32

1.9

2.0

38.50

38.88

u/l

0.01

167

471

Other systemic involvement of connective tissue

118

279

4.26

45.23

1.6

2.0

17.83

42.14

u/l

1.70

109

253

Other anaemias

167

473

3.32

43.98

2.0

39.56

40.38

u/l

0.02

157

442

Other and unspecified anaemias

166

472

3.32

43.69

1.9

2.0

39.75

40.13

u/l

0.01

156

441

COPD/asthma/ILD related infections

271

500

2.72

42.33

2.0

1.8

35.09

36.73

u/l

0.05

253

448

COPD/asthma related infections

271

500

2.72

42.33

2.0

1.8

35.09

36.73

u/l

0.05

253

448

COPD differential diagnosis

196

310

3.17

39.60

1.7

1.9

39.33

47.87

u/l

0.22

183

280

ILD differential diagnosis

196

310

3.17

39.60

1.7

1.9

39.33

47.87

u/l

0.22

183

280

Septicaemia

143

384

3.41

39.08

2.2

2.0

59.93

25.56

u/l

1.13

129

354

Abnormal findings on diagnostic imaging of lung

175

557

2.99

38.87

2.1

1.9

31.93

44.30

u/l

0.47

159

515

Autoimmune diseases related-to ILD

245

812

2.52

38.40

1.7

2.0

19.63

40.24

u/l

3.08

219

743

Excluding asthma or asthma-COPD overlap

194

312

3.12

38.22

1.7

1.9

39.70

47.56

u/l

0.20

181

282

Symptoms and signs involving the skin and subcutaneous tissue

219

804

2.58

36.85

2.2

1.8

35.83

39.06

u/l

0.11

197

731

Autoimmune diseases excluding thyroid diseases

279

619

2.45

36.56

1.6

2.0

26.46

44.71

u/l

1.25

250

573

Explicit Sepsis, including avohilmo

155

461

3.06

35.54

2.1

1.9

57.54

28.67

u/l

0.96

139

425

Autoimmune diseases excluding thyroid diseases, strict definition

269

599

2.45

35.31

1.6

2.0

26.58

45.66

u/l

1.27

241

555

Sarcoidosis

136

5.27

35.21

1.4

1.9

15.63

55.07

u/l

1.41

129

Other pulmonary diagnosis

187

312

3.01

34.82

1.8

1.9

40.89

47.56

u/l

0.16

172

282

Explicit Sepsis

152

455

3.05

34.80

2.1

1.9

58.24

28.87

u/l

0.97

137

419

Bacterial Sepsis

164

462

2.94

34.41

1.8

1.9

66.21

28.68

u/l

1.29

151

427

Coagulation defects, purpura and other haemorrhagic conditions

220

4.17

33.99

1.8

1.9

15.23

44.16

u/l

1.72

201

Polyarthropathies

203

486

2.69

33.74

1.9

31.25

41.59

u/l

0.50

182

444

Autoimmune diseases

284

620

2.33

32.90

1.7

2.0

26.40

44.67

u/l

1.25

254

574

Used for control exclusion in common control thyroid runs

268

567

2.39

32.69

1.8

2.0

28.06

47.01

u/l

1.18

242

525

Pain, not elsewhere classified

175

4.47

32.07

1.6

1.9

22.74

18.12

u/l

0.34

159

Oedema, not elsewhere classified

227

3.89

30.52

1.7

1.9

25.20

24.21

u/l

0.05

205

Headache

135

337

3.10

30.48

1.6

1.8

34.19

29.56

u/l

0.11

121

299

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

8.53

30.17

2.0

2.7

68.92

100.43

u/l

0.19

Finngen Rheumatological endpoints

241

580

2.36

29.86

1.7

1.9

33.51

41.98

u/l

0.32

219

528

Any reimbursement code in KELA

115

154

3.75

29.51

1.7

1.5

37.37

18.94

u/l

0.62

109

135

L04AX Other immunosuppressants

168

650

2.59

29.03

1.6

1.9

20.68

40.62

u/l

2.30

145

590

ILD medications: azathioprine

6.06

28.85

2.0

1.8

26.15

15.42

u/l

0.72

Implicit Sepsis

210

647

2.40

28.77

1.8

1.9

58.81

32.54

u/l

0.94

191

588

Second line medication for Crohn's disease

170

667

2.55

28.52

1.6

1.9

21.06

40.68

u/l

2.31

147

606

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

111

4.91

28.41

2.2

1.4

16.29

29.16

u/l

0.46

100

Any death

190

535

2.49

27.90

1.7

2.1

77.43

32.16

u/l

1.92

169

491

Implicit viral Sepsis, including avohilmo

104

318

3.28

27.51

1.8

55.20

29.25

u/l

0.65

297

Diagnoses used for exclusion with ILD

297

3.35

27.13

1.6

2.0

23.13

38.07

u/l

0.74

276

Other septicaemia

114

350

3.08

26.88

2.4

2.0

69.47

26.42

u/l

1.16

104

324

Other septicaemia, including avohilmo

116

359

3.04

26.74

2.4

2.0

68.34

26.44

u/l

1.15

106

333

Provisional assignment of new diseases of uncertain etiology

157

609

2.56

26.55

2.2

1.8

38.90

34.80

u/l

0.13

147

555

Codes for special purposes

157

610

2.56

26.46

2.2

1.8

38.90

34.79

u/l

0.13

147

556

All kidney diseases

247

763

2.17

26.43

1.8

1.9

50.38

34.31

u/l

0.61

224

690

Diseases of the skin and subcutaneous tissue

239

528

2.27

26.35

1.9

1.8

32.25

44.42

u/l

0.53

220

477

282

678

2.11

26.14

2.0

1.8

29.64

42.92

u/l

0.78

263

609

Certain infectious and parasitic diseases, including avohilmo

168

313

2.69

26.06

1.9

2.1

51.53

30.86

u/l

0.63

155

283

Asthma, unspecified (mode), excluding more controls

118

279

3.03

25.21

1.6

1.9

16.25

44.34

u/l

1.89

106

253

Implicit bacterial Sepsis

133

416

2.75

25.04

1.9

76.40

29.98

u/l

1.32

123

388

Malignant neoplasm of skin

107

226

3.21

24.67

2.1

1.3

14.92

23.62

u/l

0.67

200

Asthma, unspecified (mode)

122

301

2.93

24.67

1.6

1.8

16.40

48.90

u/l

2.25

110

273

Oxycodone

126

390

2.77

24.07

2.2

2.0

65.42

44.64

u/l

0.44

119

361

Infections of the skin and subcutaneous tissue

165

682

2.39

23.97

2.1

1.9

24.99

39.19

u/l

1.10

155

619

Cardiovascular diseases

132

242

2.90

23.81

1.7

31.71

26.06

u/l

0.19

123

209

Azathioprine

100

5.03

23.68

2.0

1.7

26.15

23.66

u/l

0.09

Covid-19 confirmed case

118

425

2.78

23.56

2.3

1.8

34.02

37.06

u/l

0.12

112

395

Malignant neoplasm of skin, including Hilmo

111

244

3.05

23.55

2.1

1.3

17.15

22.66

u/l

0.36

104

214

Renal tubulo-interstitial diseases

223

767

2.13

23.39

1.7

2.0

55.07

32.70

u/l

0.87

203

697

Reimbursement for rheumatic diseases

160

674

2.37

22.86

1.7

1.9

31.85

37.36

u/l

0.20

143

615

Implicit bacterial Sepsis, including avohilmo

139

452

2.56

22.74

1.9

73.30

28.92

u/l

1.33

129

419

Implicit Sepsis, including avohilmo

208

687

2.17

22.56

1.8

1.9

59.18

32.15

u/l

0.96

187

627

Localized swelling, mass and lump of skin and subcutaneous tissue

102

353

2.90

22.03

2.8

1.8

44.71

24.89

u/l

0.47

320

Persons encountering health services for other counselling and medical advice, not elsewhere classified

265

702

2.01

21.98

2.1

1.9

40.05

39.28

u/l

0.02

248

640

Pain in throat and chest

203

547

2.20

21.84

1.9

41.06

36.96

u/l

0.10

185

492

Opioids

229

557

2.13

21.84

1.8

1.9

38.87

39.79

u/l

0.03

211

506

Cardiovascular diseases (excluding rheumatic etc)

135

289

2.68

21.72

1.7

1.8

35.77

24.46

u/l

0.43

124

251

Malignant neoplasm of respiratory system and intrathoracic organs

100

4.49

21.13

2.1

1.4

17.91

31.17

u/l

0.41

Dental caries

271

3.04

20.18

1.7

2.0

20.57

53.10

u/l

1.92

250

Erysipelas, including avohilmo

164

536

2.27

20.15

1.8

1.9

31.53

28.75

u/l

0.08

152

490

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

215

3.02

20.12

2.2

1.3

17.78

23.56

u/l

0.33

190

Bacterial pneumoniae

112

371

2.66

19.99

1.9

29.28

37.85

u/l

0.40

106

338

Bacterial pneumonia, not elsewhere classified

107

349

2.70

19.69

2.0

1.9

29.09

39.33

u/l

0.48

102

320

Symptoms and signs concerning food and fluid intake

5.73

19.68

1.7

1.9

17.94

26.79

u/l

0.42

Asthma

147

309

2.46

19.44

1.6

1.9

16.09

48.01

u/l

2.27

131

279

Bacterial pneumonia (organism specified)

130

486

2.43

19.42

1.9

33.17

43.16

u/l

0.49

124

444

Asthma, excluding more controls

140

286

2.52

19.40

1.6

1.9

15.99

43.64

u/l

1.91

124

258

Abnormal findings on examination of blood, without diagnosis

143

559

2.32

19.31

1.8

2.0

47.75

39.71

u/l

0.19

127

518

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

104

233

2.82

19.01

1.9

29.32

26.87

u/l

0.08

203

Heart failure, not strict

191

613

2.10

18.94

2.0

1.9

40.58

43.02

u/l

0.07

175

556

Metabolic disorders

225

680

1.99

18.82

2.1

1.8

29.67

44.49

u/l

0.74

203

617

Symptoms and signs involving the circulatory and respiratory systems

224

556

2.02

18.71

1.7

1.9

35.87

36.65

u/l

0.02

207

500

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

208

697

2.02

18.62

1.9

58.53

31.99

u/l

0.94

188

638

Renal failure

141

524

2.30

18.40

1.7

2.1

61.64

33.97

u/l

0.82

132

485

Mantle cell lymphoma, including Hilmo

27.83

17.96

3.9

1.2

27.16

22.59

u/l

—

Bronchitis

251

804

1.87

17.76

1.9

1.8

28.76

40.95

u/l

0.74

234

727

Persons encountering health services in other circumstances, wide

257

704

1.88

17.62

2.0

1.9

34.87

39.17

u/l

0.15

235

642

All chronic kidney diseases

147

530

2.22

17.41

2.0

1.9

36.58

38.81

u/l

0.06

135

487

Benign neoplasms

225

630

1.95

17.36

1.9

29.33

42.61

u/l

0.64

206

568

Other heart diseases

101

244

2.70

17.23

1.7

1.9

38.95

26.23

u/l

0.36

215

Viral infections characterized by skin and mucous membrane lesions

120

510

2.36

17.19

2.3

1.8

43.11

36.18

u/l

0.17

108

464

Other special examinations and investigations of persons without complaint or reported diagnosis

141

303

2.36

17.14

1.9

1.5

21.25

33.29

u/l

1.15

131

274

Malignant neoplasm of digestive organs, including Hilmo

208

2.94

17.13

2.3

1.3

22.91

24.10

u/l

0.05

184

Hypertensive diseases (excluding secondary)

111

249

2.60

17.09

1.5

1.9

29.34

25.80

u/l

0.10

105

216

Condition for Implicit Sepsis (Organ dysfunction codes)

199

698

1.98

17.03

1.8

1.9

60.92

32.02

u/l

1.00

179

637

Speech therapy

286

2.84

16.99

2.3

1.9

16.02

38.11

u/l

1.62

264

Other malignant neoplasms of skin (=non-melanoma skin cancer)

210

2.85

16.82

2.2

1.3

13.73

23.67

u/l

0.74

186

Erysipelas

128

482

2.29

16.74

1.9

2.0

36.47

29.37

u/l

0.18

119

443

Asthma (mode)

138

310

2.34

16.68

1.6

1.9

15.49

47.87

u/l

2.34

122

280

Diseases of the respiratory system

136

288

2.37

16.64

1.8

48.46

45.75

u/l

0.05

127

258

Acute upper respiratory infections

239

772

1.86

16.49

2.1

1.8

23.59

42.14

u/l

1.79

221

700

Basal cell carcinoma, including Hilmo

212

2.82

16.47

2.1

1.3

20.17

23.63

u/l

0.17

188

Fitting and adjustment of other devices

330

2.57

16.13

2.3

1.8

43.26

30.73

u/l

0.33

302

Chronic kidney disease

359

2.55

16.07

1.6

2.1

47.51

28.23

u/l

0.55

334

Malignant neoplasm of digestive organs

197

2.96

16.04

2.1

1.3

22.68

24.69

u/l

0.09

176

All influenza

246

2.94

16.03

1.9

1.8

25.16

21.98

u/l

0.13

226

Other arthritis (FG)

301

2.73

16.00

1.5

2.0

21.70

42.82

u/l

1.52

275

Marginal zone B-cell lymphoma

27.71

15.76

4.2

1.4

15.49

24.33

u/l

—

Abnormalities of breathing

192

556

1.98

15.76

1.9

43.75

36.65

u/l

0.20

178

500

Caries of dentine

249

2.88

15.75

1.8

2.0

17.89

55.16

u/l

2.17

229

Symptoms and signs involving the digestive system and abdomen

226

603

1.88

15.52

1.8

1.9

44.78

39.37

u/l

0.16

210

556

Complications of surgical and medical care, not elsewhere classified

228

831

1.83

15.48

1.8

1.9

36.36

38.24

u/l

0.05

205

758

Asthma (only as main-diagnosis), excluding more controls

122

286

2.36

15.30

1.5

1.9

16.47

43.64

u/l

1.85

110

258

Malignant neoplasm of bronchus and lung, including Hilmo

100

3.85

14.89

2.1

1.4

15.40

30.41

u/l

0.51

Dermatitis

154

750

2.01

14.86

1.9

34.42

40.52

u/l

0.19

137

681

Other and unspecified dermatitis

133

633

2.11

14.58

1.9

36.79

38.96

u/l

0.05

119

576

Basal cell carcinoma

206

2.72

14.49

2.2

1.3

16.31

23.87

u/l

0.49

182

Other heart diseases, wide

193

614

1.90

14.47

1.7

1.9

47.80

31.97

u/l

0.53

176

554

Acute upper respiratory infections of multiple and unspecified sites

172

644

1.95

14.42

1.9

1.8

22.32

44.16

u/l

2.01

158

581

Asthma (only as main-diagnosis)

125

309

2.26

14.37

1.4

1.9

17.37

48.01

u/l

2.11

113

279

Hypertension, essential

166

468

2.01

14.22

1.6

2.0

37.44

34.90

u/l

0.06

159

415

Dyspnoea

209

834

1.81

13.95

2.0

1.9

43.66

36.61

u/l

0.22

194

757

Intestinal infectious diseases

212

878

1.80

13.89

1.8

1.9

26.72

39.93

u/l

1.02

198

795

Other diseases of pleura

124

506

2.13

13.74

2.0

30.68

41.21

u/l

0.58

111

475

L04AA Selective immunosuppressants

224

2.87

13.73

1.7

1.8

30.52

40.86

u/l

0.30

209

Hypertensive diseases

167

479

1.97

13.58

1.5

2.0

37.68

34.48

u/l

0.08

159

423

Hypertension

167

479

1.97

13.57

1.5

2.0

37.68

34.48

u/l

0.08

159

423

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

203

879

1.80

13.50

2.1

1.9

37.40

37.57

u/l

0.01

185

799

Zoster [herpes zoster]

210

2.92

13.49

2.6

2.0

45.39

44.35

u/l

0.01

194

Other acute lower respiratory infections

132

617

2.04

13.26

2.1

1.9

32.38

35.69

u/l

0.09

125

560

Dermatitis and eczema

244

841

1.72

13.15

2.0

1.9

28.82

39.92

u/l

0.63

222

766

Syncope and collapse

275

2.49

12.92

1.9

63.02

32.66

u/l

0.56

248

Tramadol

167

525

1.91

12.78

1.7

1.9

33.86

40.62

u/l

0.19

152

479

Care involving use of rehabilitation procedures

133

595

2.01

12.76

1.7

1.8

45.63

28.83

u/l

0.45

118

537

Diseases of oesophagus, stomach and duodenum

228

776

1.74

12.73

1.9

27.33

39.62

u/l

0.79

210

704

Other diseases of intestines

222

709

1.75

12.48

1.8

1.9

45.71

35.93

u/l

0.31

202

643

Disorders of lipoprotein metabolism and other lipidaemias

187

623

1.83

12.45

2.0

1.9

29.00

47.08

u/l

0.81

168

570

Persons encountering health services for examination and investigation

128

303

2.12

12.31

2.1

1.5

41.86

33.29

u/l

0.19

122

274

Lung cancer and mesothelioma

130

3.21

12.26

2.0

2.1

15.16

41.92

u/l

1.46

120

Other respiratory diseases principally affecting the interstitium

223

2.75

12.12

1.9

2.0

62.09

36.78

u/l

0.46

208

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

210

765

1.74

11.93

1.9

55.41

33.47

u/l

0.73

192

695

Asthma-related pneumonia

435

2.20

11.91

1.9

2.0

15.56

37.84

u/l

2.70

405

Asthma, hospital admissions 3, pneumonia

435

2.20

11.91

1.9

2.0

15.56

37.84

u/l

2.70

405

Asthma-related pneumonia or sepsis

435

2.20

11.91

1.9

2.0

15.56

37.84

u/l

2.70

405

Other specified/unspecified arthritis

283

2.52

11.88

1.4

1.9

23.33

35.46

u/l

0.91

257

Asthma, hospital admission 2, infections

140

714

1.91

11.83

1.7

1.9

16.69

41.53

u/l

4.06

128

652

Asthma-related infections

140

714

1.91

11.83

1.7

1.9

16.69

41.53

u/l

4.06

128

652

Abdominal and pelvic pain

210

603

1.75

11.66

1.9

40.30

39.37

u/l

0.02

194

556

Nausea and vomiting

262

2.54

11.53

1.8

1.7

23.21

37.69

u/l

0.70

242

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

138

3.17

11.46

2.2

1.3

39.16

26.72

u/l

0.24

123

Diarrhoea and gastroenteritis of presumed infectious origin

153

741

1.85

11.40

1.7

1.9

16.74

39.13

u/l

3.70

141

673

Follow-up examination after treatment for conditions other than malignant neoplasms

260

2.28

11.05

1.9

1.4

58.80

33.61

u/l

0.52

235

Pain (limb, back, neck, head abdominally)

146

379

1.93

11.04

2.1

1.8

42.75

39.72

u/l

0.06

137

350

Osteopathies and chondropathies

136

659

1.89

10.96

1.9

25.11

38.84

u/l

0.77

125

599

Heart failure,strict

129

463

1.95

10.81

2.0

1.9

31.56

44.91

u/l

0.42

115

425

Malignant neoplasm of eye, brain and central nervous system

9.64

10.75

1.7

1.9

14.41

76.20

u/l

0.51

Acute sinusitis

111

503

2.01

10.70

2.2

1.8

22.43

41.85

u/l

1.11

103

448

Codeine

180

549

1.77

10.68

1.9

46.22

40.20

u/l

0.14

171

498

Nutritional anaemias

120

589

1.95

10.65

2.3

1.8

27.11

41.60

u/l

0.97

113

546

Bleeding

187

762

1.72

10.63

1.8

2.0

31.17

40.95

u/l

0.60

174

696

Cough

425

2.11

10.63

2.0

1.9

32.74

33.53

u/l

0.03

382

Rheumatoid arthritis

306

2.29

10.56

1.7

1.9

40.07

39.11

u/l

0.02

281

Parasetamol

140

371

1.91

10.29

1.7

2.0

34.60

45.98

u/l

0.37

132

331

Complications of medical and surgical care

163

842

1.74

10.09

1.7

2.0

44.47

36.60

u/l

0.20

148

766

Disorders of gallbladder, biliary tract and pancreas

210

793

1.65

9.97

1.8

2.0

38.42

37.41

u/l

0.03

186

727

Endocrine, nutritional and metabolic diseases

152

419

1.83

9.90

1.8

46.67

40.89

u/l

0.13

145

383

103

514

1.99

9.88

1.6

1.9

16.42

35.19

u/l

2.11

466

Non-small cell lung cancer, including Hilmo

3.76

9.85

1.9

1.5

11.58

34.45

u/l

0.62

Other soft tissue disorders, not elsewhere classified

192

646

1.69

9.84

1.9

1.8

49.97

37.08

u/l

0.35

170

587

Pure hypercholesterolaemia

165

599

1.75

9.78

2.0

1.9

32.79

47.21

u/l

0.52

149

548

Intracranial trauma

116

402

1.95

9.76

1.6

2.0

28.19

43.80

u/l

0.62

109

365

Venous thromboembolism

129

676

1.84

9.73

2.1

1.9

53.38

37.92

u/l

0.35

118

620

Abnormalities of heart beat

375

2.15

9.73

2.1

1.9

47.75

33.78

u/l

0.26

335

Other disorders of lacrimal gland

423

2.09

9.59

1.6

2.0

24.08

37.92

u/l

0.87

390

Cellulitis

252

2.43

9.55

2.4

1.8

15.53

39.00

u/l

1.54

231

Intestinal infectious diseases, including avohilmo, including avohilmo

235

823

1.59

9.48

1.7

2.0

28.30

40.48

u/l

0.90

215

749

Pain in joint

115

363

1.95

9.45

2.0

1.8

48.18

40.25

u/l

0.14

101

333

Pleural effusion

183

2.69

9.44

1.9

2.0

16.25

47.04

u/l

1.52

174

Gastrointestinal diseases

107

265

2.03

9.29

1.8

1.7

30.55

28.95

u/l

0.04

101

244

Dialysis, with operation codes

130

3.01

9.25

1.3

2.1

87.16

21.30

u/l

0.87

120

Concussion

102

400

1.98

9.23

1.6

2.0

27.28

43.99

u/l

0.62

363

DVT of lower extremities and pulmonary embolism

101

516

1.95

9.20

2.2

1.9

45.93

36.89

u/l

0.22

479

Other viral diseases

293

2.28

9.16

2.1

1.6

23.08

38.80

u/l

0.89

267

Dorsalgia

200

646

1.64

9.06

1.8

1.9

35.01

35.72

u/l

0.02

184

584

Urticaria and erythema

387

2.10

8.99

2.0

1.8

15.11

30.84

u/l

1.53

350

Disorders of lacrimal system

102

522

1.93

8.92

1.6

2.0

22.05

35.84

u/l

1.13

481

Zoster [herpes zoster], including avohilmo

121

642

1.82

8.89

2.2

1.9

37.71

37.14

u/l

0.01

113

587

Cutaneous abscess, furuncle and carbuncle

286

2.28

8.86

2.1

1.8

27.36

38.95

u/l

0.41

263

Covid-19 suspected case

195

2.57

8.86

2.0

1.7

46.28

43.25

u/l

0.03

180

Heart failure, strict

139

545

1.77

8.84

2.0

32.49

46.26

u/l

0.48

125

507

Nephropathy related operations

134

2.92

8.79

1.3

2.1

87.91

29.10

u/l

0.73

128

Complications of procedures, not elsewhere classified

168

814

1.66

8.73

1.8

2.0

41.33

38.69

u/l

0.06

153

743

Diseases of the eye and adnexa

154

441

1.75

8.71

1.5

2.1

37.85

39.10

u/l

0.03

143

405

Other gastritis (incl. Duodenitis)

245

2.37

8.69

1.9

20.40

34.84

u/l

0.71

227

All-cause Heart Failure

136

535

1.77

8.60

2.0

33.10

46.42

u/l

0.45

122

499

Cholelithiasis, broad definition with cholecystitis

182

741

1.64

8.57

1.9

34.31

37.21

u/l

0.10

158

678

Malignant neoplasm of brain

9.04

8.54

1.2

1.8

14.72

85.67

u/l

0.50

Mantle cell lymphoma

20.64

8.52

2.9

1.3

23.08

28.75

u/l

—

Rheumatoid arthritis, including avohilmo

437

2.00

8.47

1.7

2.0

38.46

34.37

u/l

0.08

404

Seropositive rheumatoid arthritis

218

2.42

8.32

1.7

2.1

45.15

42.47

u/l

0.03

202

Acute tubulo-interstitial nephritis

131

632

1.75

8.29

1.6

1.9

37.65

30.57

u/l

0.21

119

573

Pain in limb

166

635

1.66

8.26

2.0

1.8

57.27

37.53

u/l

0.51

149

576

Disorders of thyroid, IBD co-morbidities

3.49

8.10

2.3

2.2

20.05

84.07

u/l

0.88

Disorders of eyelid, lacrimal system and orbit

181

828

1.60

8.03

1.6

2.0

20.98

41.84

u/l

2.93

161

755

Cardiac arrhythmias

115

403

1.83

8.01

1.5

1.9

34.47

36.34

u/l

0.05

107

356

Symptoms and signs involving cognition, perception, emotional state and behaviour

196

831

1.58

7.99

2.0

1.9

29.50

39.19

u/l

0.41

174

763

Disorders of other endocrine glands

481

1.91

7.94

1.5

1.8

25.61

32.71

u/l

0.32

440

Iron deficiency anaemia

509

1.87

7.85

2.3

1.8

23.27

35.84

u/l

1.03

472

Low back pain

156

638

1.65

7.71

2.2

1.9

29.62

36.10

u/l

0.25

145

576

Other and unspecified iron deficiency

390

2.00

7.69

2.2

1.9

23.66

33.86

u/l

0.61

363

Disorders of the thyroid gland

190

784

1.57

7.65

2.1

1.8

25.20

41.60

u/l

1.58

169

715

malignant neoplasm of male genital organs, including Hilmo

105

2.64

7.60

2.0

1.3

43.72

15.61

u/l

0.70

Valvular heart disease excluding rheumatic fever

102

396

1.84

7.44

2.1

1.9

53.68

35.88

u/l

0.36

362

Noninfective enteritis and colitis

101

558

1.81

7.40

1.8

1.9

27.88

35.16

u/l

0.34

503

Neurological diseases

159

484

1.65

7.37

1.8

1.9

44.79

39.43

u/l

0.12

148

439

Non-rheumatic valve diseases

101

392

1.84

7.36

2.1

1.9

54.08

35.84

u/l

0.36

359

Arthropathies

167

520

1.62

7.29

1.8

1.9

40.78

39.80

u/l

0.02

156

476

Chronic gastritis

311

2.10

7.28

1.6

1.8

60.46

34.02

u/l

0.49

288

Other viral diseases, including avohilmo

402

1.95

7.26

2.0

1.6

27.23

33.13

u/l

0.30

364

STROKE

119

459

1.75

7.23

1.7

2.0

36.73

41.19

u/l

0.11

109

417

Follow-up examination after treatment for malignant neoplasms

3.35

7.09

2.7

1.3

24.70

40.88

u/l

0.43

Cholelithiasis

170

735

1.58

7.08

1.8

1.9

33.63

37.38

u/l

0.13

147

672

Symptoms and signs involving the urinary system

160

757

1.60

7.07

1.8

1.9

43.78

38.38

u/l

0.13

150

686

Diseases of the digestive system

105

592

1.76

7.05

2.0

1.9

37.04

39.94

u/l

0.09

546

Visual disturbances

107

613

1.75

7.00

1.9

26.53

38.33

u/l

0.40

562

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

130

770

1.66

6.97

1.7

1.9

45.90

36.87

u/l

0.19

118

700

Other disorders of skin and subcutaneous tissue

152

806

1.59

6.82

2.1

1.9

28.93

39.55

u/l

0.59

143

732

Phlebitis and thrombophlebitis (not including DVT)

247

2.19

6.81

2.2

1.9

20.75

37.77

u/l

0.90

228

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

192

797

1.52

6.74

1.9

25.54

41.65

u/l

1.35

179

719

Other inflammation of eyelid

161

2.49

6.74

1.8

1.9

13.83

47.89

u/l

1.47

153

Use of hypnotics and sedatives

205

778

1.51

6.71

1.7

1.9

36.65

37.42

u/l

0.02

188

706

Personal history of malignant neoplasm

3.15

6.70

1.8

122.57

50.52

u/l

0.57

Codeine or tramadol medication

219

800

1.49

6.68

1.9

40.48

38.07

u/l

0.07

207

720

Malignant neoplasm of prostate, including Hilmo

100

2.54

6.64

2.0

1.3

47.97

15.49

u/l

0.77

Heart failure and bmi 25plus

254

1.97

6.64

1.8

1.6

21.81

46.69

u/l

1.57

229

Other disorders of fluid, electrolyte and acid-base balance

348

1.95

6.63

2.2

1.8

19.23

52.83

u/l

2.70

322

Other and unspecified visual disturbances

111

2.80

6.57

2.4

1.9

12.30

63.28

u/l

1.58

106

Other diseases of upper respiratory tract

218

765

1.49

6.55

1.7

2.0

19.60

44.07

u/l

3.58

199

696

Diseases of arteries, arterioles and capillaries

144

658

1.61

6.55

2.1

1.9

47.13

40.77

u/l

0.14

136

602

Diseases of liver

436

1.86

6.54

1.7

2.0

51.20

34.21

u/l

0.37

399

General examination and investigation of persons without complaint and reported diagnosis

104

302

1.79

6.51

1.9

1.5

40.59

33.40

u/l

0.18

273

Visual disturbances and blindness

113

671

1.68

6.51

1.9

28.25

38.67

u/l

0.36

614

Other specific joint derangements/joint disorders

134

508

1.64

6.50

1.9

40.57

40.06

u/l

0.01

118

464

Other arrhythmias

122

546

1.67

6.48

1.9

38.48

33.95

u/l

0.11

111

494

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

194

827

1.50

6.48

1.6

2.0

19.16

40.30

u/l

3.23

176

752

Spondylopathies

157

588

1.58

6.41

1.6

2.0

40.84

37.08

u/l

0.09

145

533

Malignant neoplasm of other connective and soft tissue

8.22

6.34

3.3

1.8

12.20

99.89

u/l

0.53

Other inflammation of eyelid, including avohilmo

480

1.79

6.20

1.8

1.9

23.39

35.93

u/l

0.65

440

Other reaction to severe stress, and adjustment disorders

347

1.93

6.09

2.1

1.6

35.65

30.16

u/l

0.16

315

Hyperlipidaemia, other/unspecified

440

1.78

6.01

1.7

1.9

16.48

54.77

u/l

3.81

405

Polyneuropathies and other disorders of the peripheral nervous system

263

2.06

5.86

2.1

1.9

14.42

40.78

u/l

1.95

243

Other joint disorders

155

520

1.56

5.81

1.8

1.9

35.61

39.80

u/l

0.10

144

476

Herpesviral [herpes simplex] infections

114

2.64

5.72

1.6

1.8

50.60

57.95

u/l

0.08

108

Dysphagia

259

2.05

5.71

1.5

1.8

39.93

36.11

u/l

0.05

242

Disturbances of skin sensation

280

2.00

5.67

1.6

1.7

22.12

25.43

u/l

0.14

251

Obesity due to excess calories

540

1.71

5.62

1.5

1.9

19.86

34.27

u/l

1.23

487

Lower back pain or/and sciatica

205

883

1.44

5.60

2.1

1.8

33.65

38.31

u/l

0.17

189

801

Hypothyroidism, strict autoimmune

124

508

1.60

5.56

2.0

27.13

43.90

u/l

1.12

110

469

Injury, poisoning and certain other consequences of external causes

284

1.73

5.52

1.7

2.2

38.89

33.59

u/l

0.12

257

Asthma (diagnoses ohter than nonallergic)

167

909

1.48

5.51

1.6

1.9

16.82

41.22

u/l

4.85

150

829

Other nutritional deficiencies

128

748

1.56

5.48

1.5

1.9

29.64

38.71

u/l

0.31

115

671

Diverticular disease of intestine

144

582

1.54

5.42

1.7

2.0

38.93

39.31

u/l

0.01

138

529

Chronic sinusitis

493

1.72

5.41

1.9

2.0

14.73

42.99

u/l

3.13

446

Haemorrhage from respiratory passages

364

1.80

5.37

2.0

33.61

35.38

u/l

0.06

336

Other (seronegative) rheumatoid arthritis, wide

213

2.12

5.30

2.0

22.31

42.90

u/l

0.84

199

Disorders of mineral metabolism

2.79

5.30

1.8

1.6

22.36

49.42

u/l

0.72

Dorsopathies

187

649

1.46

5.23

1.7

1.9

41.11

35.60

u/l

0.17

178

587

Other dorsopathies, not elsewhere classified

182

648

1.46

5.13

1.8

1.9

41.76

35.64

u/l

0.17

170

586

Sulfasalazine

237

2.03

5.07

1.9

1.8

78.34

23.07

u/l

0.63

216

Urinary track infection

265

1.72

5.06

1.7

1.6

46.42

30.74

u/l

0.32

236

Other and unspecified tonsillitis

252

1.91

5.05

2.2

1.7

35.80

44.89

u/l

0.18

227

Disorders of sclera, cornea, iris and ciliary body

109

691

1.58

4.97

1.7

1.9

40.36

40.72

u/l

0.01

633

Biological medication for rheuma

173

2.20

4.95

1.3

1.7

16.88

47.28

u/l

1.29

160

Other disorders of urethra and urinary system

131

598

1.52

4.85

1.9

1.8

45.31

31.42

u/l

0.44

120

542

Soft tissue disorders

182

647

1.44

4.82

1.7

1.8

39.15

37.04

u/l

0.06

168

588

Exclusions for E4_PCOS_CONSORTIUM

119

477

1.56

4.76

1.6

1.8

36.56

33.44

u/l

0.08

106

434

Conjunctivitis (acute, non atopic)

312

1.85

4.74

1.7

1.8

13.27

28.65

u/l

1.42

284

Obesity related asthma

410

1.73

4.67

1.6

2.0

14.04

40.43

u/l

2.50

372

Chronic apical periodontitis

203

815

1.40

4.63

1.9

19.02

40.31

u/l

3.45

183

745

Herpesviral [herpes simplex] infections, including avohilmo

254

1.93

4.56

1.7

35.46

35.58

u/l

0.00

231

Non-ischemic cardiomyopathy

301

1.77

4.54

2.3

2.0

21.70

42.81

u/l

1.58

284

Episodal and paroxysmal disorders

198

717

1.40

4.52

1.7

1.9

24.77

41.75

u/l

1.41

189

643

Other diseases of urinary system

181

717

1.42

4.50

2.1

1.8

50.32

34.54

u/l

0.56

166

648

488

1.62

4.48

2.1

2.0

39.85

38.78

u/l

0.02

455

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

114

749

1.52

4.43

1.7

2.0

48.01

35.27

u/l

0.25

104

687

Asthma, including avohilmo

215

864

1.37

4.39

1.7

2.0

20.18

41.72

u/l

3.06

194

789

Spondylosis

105

533

1.54

4.21

1.7

2.0

18.06

38.38

u/l

2.65

486

Dermatopolymyositis (FG)

7.02

4.17

2.1

1.4

38.80

82.58

u/l

—

Diseases of pulp and periapical tissues, including avohilmo

188

700

1.39

4.14

1.8

1.9

21.43

43.15

u/l

2.83

173

643

Diseases of pulp and periapical tissues and dental caries

123

419

1.51

4.12

2.0

1.9

33.03

45.61

u/l

0.42

114

392

Seropositive rheumatoid arthritis, wide

293

1.81

4.09

1.7

1.9

45.15

33.11

u/l

0.16

267

Other diseases of intestine

181

2.05

4.08

1.6

1.9

75.46

29.32

u/l

0.43

165

Hypothyroidism, other/unspecified

159

739

1.41

4.08

2.0

1.8

25.21

41.60

u/l

1.43

141

673

Disorders of skin appendages

580

1.56

4.04

1.8

23.57

34.54

u/l

0.72

527

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

287

1.82

4.04

1.7

1.9

46.13

33.39

u/l

0.17

262

External causes of morbidity and mortality

114

375

1.52

4.03

1.8

2.2

50.45

30.78

u/l

0.45

105

340

Actinic keratosis

453

1.61

3.97

2.0

41.97

40.21

u/l

0.03

426

Subjective visual disturbances

282

1.81

3.95

1.7

2.0

15.19

36.61

u/l

1.46

260

Skin changes due to chronic exposure to nonionizing radiation

466

1.59

3.93

2.0

41.17

39.45

u/l

0.03

437

Type 2 diabetes, wide definition

153

682

1.42

3.92

2.0

35.22

37.04

u/l

0.05

136

627

Allergic asthma (mode)

128

2.21

3.88

1.3

1.7

15.95

30.99

u/l

0.69

115

Spinal stenosis

100

483

1.53

3.86

1.9

2.0

56.73

38.17

u/l

0.35

439

Arthrosis

126

470

1.47

3.84

2.0

44.79

42.59

u/l

0.04

118

429

Other/unspecified seropositive rheumatoid arthritis

292

1.78

3.84

1.7

1.9

46.13

33.19

u/l

0.17

266

Allergic asthma (mode), excluding more controls

129

2.20

3.81

1.3

1.7

15.95

29.29

u/l

0.60

117

Diplopia

146

2.13

3.79

1.7

1.9

16.97

53.28

u/l

1.39

139

Candidiasis, including avohilmo

331

1.72

3.76

1.8

1.9

65.08

27.57

u/l

0.52

301

Symptoms and signs involving the nervous and musculoskeletal systems

111

756

1.47

3.74

1.9

35.35

37.51

u/l

0.05

687

Exposure to unspecified factor

182

912

1.36

3.71

1.5

2.0

28.78

38.92

u/l

0.49

162

834

Other disorders of eye and adnexa

154

2.08

3.71

1.3

1.8

14.45

50.09

u/l

1.38

146

Diseases of male genital organs

100

328

1.54

3.70

2.1

1.9

44.25

32.06

u/l

0.31

306

Hypothyreosis and Thyroxine purchase for inclusion criteria

164

778

1.38

3.70

2.0

1.8

26.63

37.45

u/l

0.86

146

707

Ischaemic heart disease, wide definition

147

642

1.41

3.70

1.8

2.0

50.75

40.52

u/l

0.21

136

588

Obesity

112

721

1.46

3.67

1.5

1.9

32.49

35.44

u/l

0.08

100

649

Obesity and other hyperalimentation

112

721

1.46

3.65

1.5

1.9

32.49

35.44

u/l

0.08

100

649

Epilepsy

363

1.68

3.65

1.5

1.9

28.30

39.20

u/l

0.45

321

Coronary atherosclerosis

128

562

1.44

3.60

1.8

2.0

33.28

46.61

u/l

0.38

117

517

Caries of dentine, including avohilmo

144

520

1.42

3.59

2.0

31.38

41.20

u/l

0.38

135

479

Disorders of conjunctiva

146

813

1.39

3.56

1.8

1.9

46.51

36.17

u/l

0.24

132

737

Cystitis

148

630

1.40

3.54

2.2

1.8

36.96

30.37

u/l

0.22

134

570

Valvular operations

137

2.12

3.54

1.3

2.1

22.44

36.15

u/l

0.62

130

Gonarthrosis [arthrosis of knee](FG)

124

496

1.44

3.47

2.0

53.24

45.16

u/l

0.13

114

455

Gonarthrosis

112

433

1.46

3.40

2.0

57.13

43.47

u/l

0.23

105

399

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

373

1.64

3.36

1.7

1.8

17.52

31.31

u/l

1.04

340

Disorders of lens

130

571

1.41

3.35

1.8

2.0

60.64

40.00

u/l

0.41

117

524

Malignant neoplasm of testis

8.64

3.27

2.7

1.1

11.00

11.79

u/l

—

Malignant neoplasm of testis, including Hilmo

8.63

3.27

2.7

1.1

11.00

11.79

u/l

—

Other pleural conditions

116

2.16

3.21

1.4

2.0

14.58

45.84

u/l

1.32

109

Melanocytic naevi

355

1.64

3.20

1.7

1.8

21.30

32.61

u/l

0.44

320

Hyperplasia of prostate

278

1.56

3.19

2.6

2.0

73.30

32.86

u/l

0.72

259

Dental caries, including avohilmo

132

482

1.40

3.17

2.0

32.92

42.16

u/l

0.32

124

447

Nerve, nerve root and plexus disorders

187

852

1.32

3.14

1.8

1.9

59.94

33.44

u/l

0.84

167

778

Psoriasis

342

1.64

3.13

1.7

1.8

15.64

40.61

u/l

2.07

315

Benign neoplasm of other and unspecified endocrine glands

145

2.00

3.09

1.6

1.9

34.56

51.41

u/l

0.36

139

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

7.58

3.06

3.5

1.4

13.12

25.51

u/l

—

Cerebrovascular diseases

139

706

1.37

3.04

1.8

2.0

22.47

44.41

u/l

2.46

126

647

Temporomandibular joint disorders, including avohilmo

440

1.54

3.03

1.4

1.8

13.44

29.28

u/l

1.84

396

Constipation

162

823

1.33

3.03

1.8

1.9

23.24

41.53

u/l

2.11

148

749

Disorders of choroid and retina

152

792

1.34

3.00

2.1

1.9

39.96

40.57

u/l

0.01

143

722

Dental operations

113

408

1.43

2.99

2.1

2.0

23.49

46.02

u/l

1.85

105

379

Dizziness and giddiness

135

771

1.36

2.96

2.1

1.9

32.64

38.71

u/l

0.26

121

708

Falls/tendency to fall

183

698

1.31

2.93

1.6

2.0

36.16

36.18

u/l

0.00

168

631

Injuries to the wrist and hand

177

896

1.31

2.92

1.8

1.9

51.78

34.73

u/l

0.53

160

815

Papulosquamous disorders

501

1.50

2.88

1.8

1.9

19.52

38.27

u/l

1.69

457

Chronic lower respiratory diseases

204

834

1.29

2.87

1.8

1.9

27.17

40.39

u/l

1.04

184

759

Gingivitis and periodontal diseases

176

692

1.31

2.85

1.7

2.0

23.08

37.70

u/l

1.73

164

628

Fall on same level

193

794

1.30

2.85

1.6

2.0

24.98

37.70

u/l

0.73

177

720

Use of donepezil

260

0.37

2.78

2.1

1.9

14.93

42.82

u/l

—

244

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

104

677

1.40

2.78

1.9

1.8

29.69

36.55

u/l

0.30

616

Seminoma of testis

8.44

2.76

1.2

12.60

10.58

u/l

—

Heart failure and coronary heart disease

419

1.46

2.76

2.0

21.34

52.55

u/l

2.53

397

Seminoma of testis, including Hilmo

8.42

2.75

1.2

12.60

10.58

u/l

—

Other external causes of accidental injury

140

519

1.35

2.75

1.6

2.1

29.87

41.45

u/l

0.43

128

471

Neuromuscular dysfunction of bladder

2.20

2.73

1.1

1.8

14.72

41.51

u/l

0.71

Insulin medication

110

660

1.38

2.71

1.9

2.0

34.65

37.07

u/l

0.05

100

606

Senile cataract

119

526

1.38

2.71

1.9

2.0

71.05

40.43

u/l

0.62

108

487

Viral and other specified intestinal infections

163

1.86

2.69

1.5

1.7

14.93

53.32

u/l

1.62

152

Stroke, excluding SAH

114

599

1.37

2.65

1.8

2.0

23.97

44.41

u/l

1.86

103

552

Congenital malformations, deformations and chromosomal abnormalities

632

1.41

2.65

1.9

1.8

24.37

33.71

u/l

0.50

575

Excessive, frequent and irregular menstruation

203

1.58

2.64

1.7

1.6

58.30

28.58

u/l

0.42

182

Colectomy operation

198

1.77

2.62

2.5

1.9

67.30

38.02

u/l

0.26

181

Hard cardiovascular diseases

144

641

1.33

2.61

1.7

2.0

17.74

47.93

u/l

4.09

131

588

Tumor necrosis factor alpha inhibitors

155

1.87

2.60

1.3

1.7

13.80

36.73

u/l

1.24

144

Ischemic heart diseases

145

652

1.32

2.59

1.8

2.0

30.37

43.08

u/l

0.43

132

598

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

7.22

2.55

2.0

1.3

6.14

25.76

u/l

—

Other diseases of lip and oral mucosa

525

1.45

2.52

1.9

16.28

38.49

u/l

2.31

480

Percutaneous Coronary Intervention

139

639

1.32

2.49

1.9

2.0

18.41

43.48

u/l

3.64

126

586

Coronary revascularization (ANGIO or CABG)

139

639

1.32

2.47

1.9

2.0

18.39

43.48

u/l

3.65

126

586

Injuries to the head

190

889

1.27

2.47

1.7

1.9

45.12

35.77

u/l

0.27

176

805

Cholecystitis

151

1.86

2.46

1.9

2.1

42.01

45.04

u/l

0.06

140

Other benign neoplasms of skin

448

1.47

2.41

2.3

1.9

17.50

35.15

u/l

1.60

414

Hernia

158

814

1.29

2.40

1.9

25.67

39.13

u/l

0.75

146

741

Anxiety disorders, excluding more controls

141

688

1.31

2.39

1.9

41.56

32.37

u/l

0.31

126

631

Sciatica+with lumbago

550

1.40

2.38

2.0

1.9

48.96

37.02

u/l

0.22

496

Arterial embolism and thrombosis

2.35

2.38

2.3

1.5

65.55

62.09

u/l

0.03

Malignant neoplasm of parotid gland

6.33

2.38

3.0

1.4

25.60

25.85

u/l

—

Malignant neoplasm of parotid gland, including Hilmo

6.31

2.38

3.0

1.4

25.60

25.85

u/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

110

741

1.35

2.38

1.9

34.65

42.14

u/l

0.19

100

681

Stroke, including SAH

117

627

1.34

2.36

1.8

2.0

25.01

42.82

u/l

1.55

105

578

Demyelinating diseases of the central nervous system

2.15

2.34

1.2

1.8

9.24

45.90

u/l

1.13

Other functional intestinal disorders

521

1.41

2.34

2.0

24.68

34.55

u/l

0.69

473

Conjunctivitis

124

755

1.32

2.34

1.7

1.9

32.07

34.63

u/l

0.07

110

685

Injuries to the hip and thigh

583

1.38

2.32

1.8

1.9

19.41

41.39

u/l

2.63

538

Other disorders of veins

469

1.45

2.31

1.6

1.8

24.92

35.09

u/l

0.41

430

Anxiety disorders

147

780

1.29

2.30

1.8

1.9

40.48

37.59

u/l

0.08

130

710

Hypothyroidism, strict autoimmune, 3 medication purchases required

138

711

1.30

2.30

2.0

1.8

30.81

37.67

u/l

0.34

124

644

Diabetic retinopathy, excluding more controls

134

1.67

2.25

2.0

1.7

16.53

60.45

u/l

1.60

121

Shoulder lesions

130

593

1.31

2.25

2.0

1.9

41.91

38.90

u/l

0.06

117

539

Migraine

397

1.43

2.23

1.5

1.8

14.48

32.78

u/l

1.65

352

Malignant neoplasm of bone and articular cartilage

5.61

2.22

6.4

1.3

8.56

23.34

u/l

—

Neurotic, stress-related and somatoform disorders

145

776

1.29

2.22

1.8

1.9

40.47

37.80

u/l

0.07

129

705

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

2.86

2.20

1.2

1.5

33.85

58.42

u/l

—

Focal epilepsy

250

1.60

2.14

1.4

1.9

30.52

39.82

u/l

0.30

229

Abnormal involuntary movements

144

1.81

2.14

1.8

30.23

53.44

u/l

0.54

137

Type of accident

338

1.51

2.12

2.6

1.8

30.27

34.32

u/l

0.08

314

Asthma, hospital admissions , main diagnosis only

135

914

1.28

2.12

1.5

1.9

17.05

39.86

u/l

4.31

121

831

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

614

1.37

2.12

2.0

13.81

46.13

u/l

4.30

558

Malignant neoplasm of pancreas, including Hilmo

2.45

2.10

1.8

1.6

24.64

45.14

u/l

0.28

Accidents

134

519

1.29

2.04

1.6

2.1

31.03

41.45

u/l

0.36

122

471

Conjunctivitis (acute, non atopic), including avohilmo

170

821

1.25

2.04

1.6

2.0

15.94

38.31

u/l

4.51

156

746

Sleep apnoea, including avohilmo

173

839

1.25

2.03

1.8

1.9

25.92

41.04

u/l

0.97

162

758

Major coronary heart disease event

147

692

1.27

2.02

2.0

16.80

46.95

u/l

4.61

133

635

Atopic dermatitis

503

1.36

2.01

2.0

1.7

46.94

33.68

u/l

0.27

452

Insulin, intermediate and long-acting

695

1.33

2.01

2.0

1.9

36.21

39.61

u/l

0.07

639

Emergency coronary revascularization (for ACS)

149

710

1.27

2.00

1.9

2.0

18.27

45.85

u/l

4.05

135

652

Coxarthrosis [arthrosis of hip](FG)

434

1.36

1.99

1.7

2.1

50.36

49.36

u/l

0.02

400

Intracranial injury

102

721

1.32

1.98

1.5

2.0

23.89

37.61

u/l

0.76

656

Insomnia

856

0.75

1.95

1.5

1.9

32.32

35.65

u/l

0.08

779

Polycystic ovarian syndrome, consortium definition

100

431

1.33

1.93

1.7

62.16

29.07

u/l

0.70

385

Cholecystectomy

121

800

1.28

1.93

1.9

30.34

37.37

u/l

0.22

107

730

Leiomyoma of uterus

369

1.35

1.91

1.7

1.9

25.15

40.16

u/l

0.68

329

Diaphragmatic hernia

463

1.41

1.91

2.0

22.41

43.27

u/l

1.34

426

Other intervertebral disc disorders

131

612

1.28

1.89

1.7

1.9

17.31

36.31

u/l

2.98

120

554

Obesity, other/unspecified

356

1.46

1.89

1.5

1.8

51.92

29.99

u/l

0.33

323

Seropositive rheumatoid arthritis, strict definition

166

1.69

1.87

1.6

1.8

78.04

40.71

u/l

0.28

155

Nontoxic diffuse goitre

2.87

1.86

3.0

1.6

8.41

97.69

u/l

—

Angina pectoris

103

521

1.31

1.86

1.8

2.0

52.33

47.61

u/l

0.07

481

Menorrhagia

191

1.49

1.85

1.7

63.39

28.98

u/l

0.41

172

Ischaemic Stroke, excluding all haemorrhages

103

580

1.31

1.85

1.9

2.0

22.44

41.06

u/l

1.87

538

Malignant neoplasm of urinary organs, including Hilmo

2.21

1.84

2.0

1.5

15.82

38.26

u/l

0.43

Keratitis

425

1.41

1.83

1.6

1.9

26.80

37.95

u/l

0.40

391

Iron deficiency anaemia secondary to blood loss (chronic)

175

1.66

1.82

2.7

1.9

31.37

50.35

u/l

0.51

161

Malignant neoplasm of urinary organs

2.27

1.80

2.1

1.4

16.31

40.77

u/l

0.42

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

2.27

1.80

2.0

1.4

13.38

40.77

u/l

0.49

Cutaneous lupus erythematosus

2.77

1.79

1.4

1.3

10.61

61.59

u/l

—

Other neurological diseases

125

765

1.27

1.79

2.0

1.9

31.30

41.73

u/l

0.35

118

700

Ovarian cyst

198

1.47

1.78

1.7

1.6

14.53

28.63

u/l

1.02

177

Other degenerative diseases of the nervous system

237

1.48

1.77

2.1

12.45

38.86

u/l

3.42

218

Discitis, unspecified

3.35

1.75

3.2

2.1

13.02

17.17

u/l

—

Continuous positive airway pressure

166

1.61

1.74

1.5

2.1

28.22

39.78

u/l

0.38

153

Morphin

2.93

1.72

2.1

14.21

62.72

u/l

—

Persons encountering health services in other circumstances

434

1.39

1.72

1.9

1.7

16.21

42.16

u/l

2.42

393

Special screening examination for infectious and parasitic diseases

128

1.65

1.72

1.5

1.3

24.07

26.52

u/l

0.06

115

Adjustment and management of implanted device

163

1.66

1.70

2.0

1.9

18.45

31.34

u/l

0.76

152

Malignant neoplasm of kidney, except renal pelvis

2.30

1.70

2.1

1.5

13.68

44.09

u/l

0.49

Disorders of breast

439

1.36

1.68

2.1

1.7

40.37

34.73

u/l

0.07

394

Unspecified lump in breast

149

1.68

1.66

2.1

1.8

14.82

42.78

u/l

1.42

138

Schizophrenia

163

0.43

1.65

2.0

1.8

22.73

38.08

u/l

—

154

Diabetes mellitus

165

782

1.22

1.62

1.7

1.9

28.11

35.08

u/l

0.30

146

712

Other disorders of ear

157

830

1.22

1.62

2.0

1.9

24.91

40.68

u/l

0.98

147

752

malignant neoplasm of female genital organs, including Hilmo

100

1.81

1.61

1.2

1.4

19.08

32.81

u/l

0.42

Supplementary factors related to causes of morbidity and mortality classified elsewhere

369

1.41

1.61

2.6

1.8

29.74

35.76

u/l

0.13

344

Disorders of ocular muscles, binocular movement, accommodation and refraction

562

1.32

1.57

1.4

1.8

29.53

33.29

u/l

0.13

512

Benign neoplasm: Cerebral meninges

114

1.76

1.56

1.6

1.8

19.89

63.15

u/l

1.24

109

Other headache syndromes

481

1.35

1.54

1.8

1.9

35.73

36.22

u/l

0.01

421

Coxarthrosis

403

1.31

1.54

1.7

2.0

51.20

45.51

u/l

0.10

374

Migraine, single triptan purchase ok & required. ICD-code if available is included

112

603

1.26

1.53

1.6

1.8

18.57

34.02

u/l

1.33

102

544

Triptan medication for migraine, single purchase ok

112

603

1.26

1.53

1.6

1.8

18.57

34.02

u/l

1.33

102

544

Diseases of the ear and mastoid process

184

770

1.20

1.50

2.0

1.8

33.09

40.89

u/l

0.35

167

695

Mycoses, including avohilmo

149

934

1.21

1.50

1.6

1.9

43.10

36.46

u/l

0.17

134

851

Diabetes, varying definitions

163

784

1.21

1.47

1.7

1.9

28.48

34.99

u/l

0.27

144

714

Conduction disorders

266

1.42

1.47

2.3

2.0

69.04

34.41

u/l

0.49

247

Malignant neoplasm of pancreas

2.37

1.45

2.0

1.6

29.96

56.36

u/l

—

Benign neoplasm: Colon

713

1.26

1.44

1.9

2.0

45.96

41.11

u/l

0.09

653

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

327

1.41

1.44

1.6

1.8

80.31

40.35

u/l

0.37

298

Sleep apnoea

160

839

1.20

1.43

1.9

27.90

41.11

u/l

0.74

151

756

Diseases of oral cavity, salivary glands and jaws

388

1.28

1.42

1.8

2.0

22.32

51.62

u/l

2.51

362

Benign neoplasm of colon, rectum, anus and anal canal

111

756

1.24

1.42

1.9

2.0

42.61

40.40

u/l

0.04

102

693

Other arthrosis

425

1.29

1.41

1.6

2.0

58.19

43.43

u/l

0.22

392

Sleep disorders

100

859

0.80

1.40

1.6

1.9

31.18

38.95

u/l

0.21

782

Disorders of vitreous body

652

1.27

1.37

1.6

2.0

18.29

44.36

u/l

3.12

600

Somatoform disorder

158

1.58

1.37

1.7

1.8

20.14

41.63

u/l

0.81

150

Dipeptidyl peptidase 4 (DPP-4) inhibitors

620

1.25

1.36

2.0

35.45

42.77

u/l

0.19

568

Other anxiety disorders

412

1.32

1.35

1.8

1.6

47.17

28.56

u/l

0.34

372

Mood disorders, excluding more controls

153

750

1.20

1.34

1.8

1.9

37.58

33.87

u/l

0.12

140

692

Disorders of refraction and accommodation

298

1.40

1.32

1.3

1.7

28.68

31.83

u/l

0.09

275

Disorders of vitreous body and globe

669

1.26

1.32

1.6

2.0

18.13

43.53

u/l

3.12

616

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

386

1.35

1.28

1.4

1.9

59.28

37.20

u/l

0.22

356

Presence of other functional implants

545

1.24

1.28

2.1

2.0

58.19

37.85

u/l

0.33

503

Lung diseases due to external agents

161

1.55

1.28

2.0

43.21

51.45

u/l

0.12

148

Artrosis, including avohilmo

136

617

1.21

1.27

1.9

48.92

36.56

u/l

0.31

127

555

Benign neoplasm of meninges

122

1.64

1.27

1.6

1.8

19.89

60.42

u/l

1.23

116

Vascular dementia

112

0.43

1.25

1.4

1.9

13.12

45.24

u/l

—

105

Other cataract

456

1.27

1.24

1.7

2.0

23.24

42.69

u/l

1.15

423

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

152

759

1.19

1.23

1.8

1.9

29.00

35.45

u/l

0.23

137

694

Inflammatory diseases of female pelvic organs

450

1.26

1.23

1.8

1.7

25.59

36.59

u/l

0.53

404

Injuries to the shoulder and upper arm

140

906

1.19

1.22

1.7

2.0

51.92

35.87

u/l

0.38

127

830

Diabetes medication

165

818

1.18

1.21

1.9

46.62

34.53

u/l

0.32

149

744

Diseases of middle ear and mastoid

540

1.26

1.21

2.4

1.7

35.48

28.57

u/l

0.26

488

Other symptoms and signs involving the nervous and musculoskeletal systems

496

1.29

1.19

1.8

1.9

50.15

34.61

u/l

0.25

451

Macular pucker

205

1.47

1.19

1.7

2.1

83.23

42.62

u/l

0.28

189

All anxiety disorders

542

1.25

1.18

1.7

1.8

43.66

33.02

u/l

0.23

490

Benign lipomatous neoplasm

341

1.35

1.17

1.8

2.0

26.05

33.17

u/l

0.28

315

Depression or dysthymia

108

483

1.22

1.16

1.8

2.0

27.65

34.17

u/l

0.34

448

Primary gonarthrosis, bilateral

610

1.24

1.15

2.0

15.45

39.06

u/l

3.48

559

Xerosis cutis

2.51

1.15

3.6

1.5

9.30

20.54

u/l

—

Nonsuppurative otitis media

186

1.45

1.14

2.8

1.6

22.53

43.29

u/l

0.81

174

Mood disorders

160

873

1.17

1.14

1.8

1.9

36.82

37.73

u/l

0.03

146

793

Other retinal disorders

110

692

1.21

1.13

2.0

1.9

46.28

42.88

u/l

0.06

104

635

Other symptoms and signs involving cognitive functions and awareness

577

1.24

1.12

1.6

2.0

34.63

39.20

u/l

0.08

534

Other bursopathies

151

1.53

1.11

1.8

1.9

12.28

30.77

u/l

1.48

143

Gastro-oesophageal reflux disease

106

740

1.21

1.11

2.0

32.10

39.96

u/l

0.21

672

Presence of cardiac and vascular implants and grafts

439

1.26

1.11

2.2

2.0

16.81

38.12

u/l

2.66

409

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

140

1.44

1.10

1.6

1.4

19.74

28.75

u/l

0.34

123

Benzodiazepine use

159

920

1.17

1.09

1.8

1.9

32.67

38.24

u/l

0.21

149

832

Diabetes, insulin treatment (Kela reimbursement)

161

821

1.17

1.09

1.8

1.9

28.42

38.85

u/l

0.43

146

748

Mood [affective] disorders

159

873

1.17

1.08

1.8

1.9

37.00

37.73

u/l

0.02

145

793

Behavioural syndromes associated with physiological disturbances and physical factors

109

881

0.84

1.06

1.6

1.9

30.01

39.40

u/l

0.28

804

Type 2 diabetes, definitions combined

150

746

1.17

1.05

1.8

2.0

29.91

35.91

u/l

0.23

135

679

Type 2 diabetes

154

764

1.17

1.05

1.8

1.9

28.96

35.50

u/l

0.26

138

695

Type 2 diabetes, strict (exclude DM1)

151

752

1.17

1.04

1.8

2.0

29.72

37.91

u/l

0.33

136

684

Disorders of synovium and tendon

558

1.23

1.04

2.1

1.8

59.74

38.43

u/l

0.30

504

Postpartum care and examination

0.44

1.03

1.4

1.2

28.44

37.08

u/l

—

Disease of hard tissues of teeth, NOS

370

1.23

1.03

1.9

2.0

18.02

51.96

u/l

3.06

345

Cervical disc disorders

428

1.29

1.03

1.8

2.0

52.89

39.39

u/l

0.18

389

Irregular menses

333

1.29

1.03

1.6

1.7

23.16

28.37

u/l

0.26

295

Conductive and sensorineural hearing loss

134

757

1.17

1.02

1.9

2.0

25.48

43.00

u/l

0.94

125

691

Type 2 diabetes, definitions combined, including avohilmo

150

745

1.16

1.00

1.8

2.0

29.92

38.19

u/l

0.33

135

676

Maternal care for known or suspected malpresentation of fetus

0.51

1.00

1.6

1.3

10.50

30.14

u/l

—

Other obstetric conditions, not elsewhere classified

149

1.40

0.99

1.5

1.4

19.16

27.39

u/l

0.33

132

Cervicalgia

223

1.39

0.98

2.1

1.9

64.44

22.09

u/l

0.39

199

Necrosis of pulp, including avohilmo

696

1.21

0.94

1.8

1.9

20.69

38.61

u/l

1.78

625

Alopecia areata

2.23

0.93

1.3

2.0

25.32

99.93

u/l

—

Other and unspecified disorders of vitreous body

539

1.23

0.93

1.7

2.0

19.22

42.34

u/l

2.24

496

Acute and transient psychotic disorders

120

0.50

0.93

2.2

1.9

10.55

44.08

u/l

—

113

Obsessive-compulsive disorder

1.73

0.92

1.8

1.7

15.71

33.73

u/l

—

Any mental disorder

172

755

1.14

0.89

1.9

47.89

33.76

u/l

0.37

151

697

Psychiatric diseases

160

699

1.15

0.88

1.9

2.0

51.49

34.68

u/l

0.43

143

646

Other fall from one level to another

263

1.33

0.87

1.5

1.9

20.14

36.15

u/l

0.70

242

Other antidepressants

160

714

1.14

0.86

1.8

2.0

30.74

37.92

u/l

0.28

146

657

Unspecified/other endometriosis

1.63

0.85

1.5

18.75

40.90

u/l

—

Meniscus derangement

441

1.20

0.84

2.0

48.70

42.65

u/l

0.09

408

Other specified/unspecified hearing loss

104

1.54

0.84

2.2

1.9

16.72

67.90

u/l

1.40

Urolithiasis

433

1.25

0.84

2.4

1.9

11.43

43.59

u/l

3.76

397

Dermatophytosis

154

1.43

0.83

1.5

1.9

15.51

52.19

u/l

1.50

144

Emphysema

1.55

0.81

2.7

1.9

36.20

71.61

u/l

0.66

Benign neoplasm: Vulva

0.00

0.79

0.0

1.4

—

110.39

—

Transient ischemic attack

565

1.18

0.78

1.9

2.0

38.61

41.66

u/l

0.06

526

Vascular disorders of the intestines

1.59

0.78

1.1

2.1

24.08

37.22

u/l

0.31

Inguinal hernia

538

1.17

0.77

2.2

2.0

34.33

43.95

u/l

0.25

499

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

398

1.24

0.76

1.7

1.6

48.31

34.62

u/l

0.15

361

Injuries to the knee and lower leg

185

894

1.12

0.74

1.5

2.0

27.92

38.98

u/l

0.57

163

819

Depression

143

843

1.13

0.74

1.8

1.9

38.91

37.50

u/l

0.04

130

764

Hallux rigidus

132

0.61

0.73

2.0

14.25

44.35

u/l

—

121

Perioral dermatitis

2.00

0.72

1.6

1.8

21.52

106.21

u/l

—

Complications of labour and delivery

372

0.82

0.71

1.8

1.7

38.68

37.88

u/l

0.01

332

Non-selective monoamine reuptake inhibitors

442

1.22

0.71

1.9

89.89

34.31

u/l

0.75

408

Dementia

434

0.82

0.71

2.3

2.0

13.52

46.41

u/l

4.20

407

Dislocation, sprain and strain of joints and ligaments of thorax

1.75

0.71

1.1

2.0

14.31

70.21

u/l

—

Artificial joint operation, meniscal resection

145

822

1.13

0.70

1.8

2.0

43.25

38.76

u/l

0.09

135

753

Major coronary heart disease event excluding revascularizations

100

571

1.16

0.69

1.8

2.0

28.36

51.19

u/l

1.33

527

Fracture of femur

311

1.25

0.69

1.7

2.0

16.98

39.44

u/l

1.86

291

Nonsuppurative otitis media, including avohilmo

275

1.26

0.69

2.5

1.6

22.25

34.61

u/l

0.64

258

Corneal ulcer

204

1.32

0.68

1.9

1.8

32.52

42.92

u/l

0.16

189

Infections with a predominantly sexual mode of transmission, including avohilmo

358

1.23

0.67

1.4

1.6

12.53

35.39

u/l

2.18

324

Suppurative and unspecified otitis media

307

1.24

0.66

2.1

1.6

33.97

35.90

u/l

0.04

284

Medical abortion

369

1.17

0.66

1.5

1.7

54.13

34.07

u/l

0.29

334

Periodontitis

153

872

1.12

0.65

1.7

2.0

55.70

35.00

u/l

0.49

135

797

Other and unspecified follicular disorders

1.59

0.65

2.4

1.9

54.99

72.03

u/l

—

Sensorineural hearing loss

124

731

1.13

0.65

1.8

2.0

26.46

44.11

u/l

0.87

116

666

Wet age-related macular degeneration

227

0.72

0.63

2.9

1.9

54.97

44.56

u/l

0.13

212

Abnormal serum enzyme levels

390

1.21

0.63

2.2

2.1

87.95

45.31

u/l

0.46

363

Other disorders starting during childhood or adolecense, excluding more controls

1.70

0.63

2.0

1.4

36.88

14.06

u/l

—

Volume depletion

104

1.44

0.62

2.0

1.7

13.78

52.63

u/l

1.49

Dementia, including avohilmo

461

0.84

0.61

2.2

2.1

45.55

41.52

u/l

0.05

434

Benign neoplasm: Other/unspecified site

0.00

0.60

0.0

1.5

—

83.11

—

Open wound of thorax

0.00

0.60

0.0

2.0

—

13.50

—

Glaucoma, exfoliation

138

0.65

0.60

2.2

2.0

9.02

57.38

u/l

—

130

Glucosamine medication

493

1.17

0.60

1.6

2.0

59.33

41.49

u/l

0.28

455

Pyogenic granuloma

0.00

0.60

0.0

1.4

—

81.59

—

Alcohol use disorder, Swedish definition

678

0.86

0.58

1.7

2.0

83.30

37.24

u/l

0.58

617

Endometriosis ASRM stages 3,4

231

0.74

0.58

1.6

1.7

59.50

37.93

u/l

0.20

207

Diabetic retinopathy

241

1.21

0.57

1.9

20.10

49.09

u/l

1.56

220

Malignant neoplasm of bladder

1.71

0.57

3.3

1.2

16.85

57.90

u/l

—

Anomalies of dental arch relationship, including avohilmo

167

0.70

0.57

1.1

1.7

164.05

46.05

u/l

0.37

155

Other and unspecified acute skin changes due to ultraviolet radiation

1.67

0.56

2.3

1.7

20.23

57.20

u/l

—

Gonarthrosis, primary, with knee surgery

645

1.13

0.55

2.0

52.07

38.50

u/l

0.22

593

Unspecific neurodegenerative disorder

413

0.84

0.54

2.2

2.0

13.98

44.32

u/l

4.04

391

Other (not insulin) diabetes medications

148

786

1.10

0.54

2.0

1.9

39.72

35.18

u/l

0.11

132

716

Chronic periodontitis, including avohilmo

151

874

1.10

0.53

1.7

2.0

55.77

35.04

u/l

0.48

133

799

FESS (DNB20)

125

1.36

0.53

2.1

2.0

15.62

54.40

u/l

1.24

118

Caries of enamel

120

872

0.90

0.53

1.6

1.9

36.64

37.89

u/l

0.02

104

795

Fracture of forearm

622

1.14

0.52

1.8

54.12

32.81

u/l

0.40

573

Unspecified urinary incontinence

0.62

0.52

1.3

1.8

23.15

53.70

u/l

—

Allergic conjunctivitis

623

1.14

0.51

1.7

1.8

44.37

30.80

u/l

0.27

561

Rotator cuff syndrome

555

1.13

0.51

1.9

35.61

39.19

u/l

0.07

506

Anxiety (asthma-related co-morbidities)

556

1.13

0.50

1.7

1.8

44.11

26.80

u/l

0.41

504

Spontaneous abortion

292

0.82

0.50

1.8

1.7

10.51

35.44

u/l

2.76

260

Injury of eye and orbit

153

1.31

0.50

1.9

15.39

35.04

u/l

0.96

142

Organic, including symptomatic, mental disorders

531

0.87

0.48

2.1

2.0

15.44

44.68

u/l

3.69

497

Injuries to the ankle and foot

101

774

1.11

0.47

1.8

31.84

35.41

u/l

0.07

702

Recurrent or chronic depression

328

1.16

0.47

1.9

2.0

28.94

29.97

u/l

0.03

305

Special screening examination for other diseases and disorders

0.62

0.45

1.0

1.2

22.86

39.52

u/l

—

Calculus of kidney and ureter

403

1.17

0.45

2.3

1.9

11.92

44.44

u/l

3.41

368

Acute appendicitis

811

1.11

0.44

2.3

1.8

17.77

40.08

u/l

3.23

736

721

0.89

0.42

1.7

1.9

99.76

33.37

u/l

0.88

656

Infective bursitis

1.56

0.42

1.2

1.6

16.04

46.80

u/l

—

Other problems related to primary support group, including family circumstances

0.63

0.42

1.3

1.8

113.73

41.47

u/l

—

Vestibular neuronitis

0.63

0.42

2.8

1.8

92.10

66.54

u/l

—

Antepartum haemorrhage, not elsewhere classified

1.43

0.41

1.8

1.4

17.15

50.85

u/l

—

Panniculitis affecting regions of neck and back

1.52

0.41

1.0

1.8

11.86

44.75

u/l

—

Other disorders of binocular vision

0.00

0.41

0.0

1.7

—

29.17

—

Family history of other specific disorders

0.00

0.41

0.0

1.4

—

82.79

—

Pre-eclampsia or poor fetal growth

260

0.80

0.41

1.8

1.5

9.47

38.71

u/l

2.13

226

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

0.00

0.41

0.0

1.5

—

99.56

—

710

0.89

0.41

1.6

1.9

96.98

34.28

u/l

0.77

647

Occlusion and stenosis of arteries, not leading to stroke

0.00

0.40

0.0

1.7

—

12.45

—

Torsion of ovary, ovarian pedicle and fallopian tube

0.00

0.40

0.0

2.0

—

95.88

—

Deep bite

0.67

0.39

1.0

1.8

279.40

44.40

u/l

—

Injuries to the elbow and forearm

103

804

1.10

0.39

1.8

1.9

45.15

33.14

u/l

0.27

733

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

526

0.89

0.39

1.8

1.9

40.32

29.48

u/l

0.27

473

Overjet

0.00

0.39

0.0

1.5

—

20.05

—

Degenerative diseases of the nervous system

364

0.87

0.38

2.3

2.0

14.70

42.64

u/l

3.03

345

Gestational diabetes (for exclusion)

208

0.83

0.38

1.5

1.4

19.75

30.10

u/l

0.41

185

Other hammer toe(s) (acquired)

154

1.24

0.37

2.6

1.9

14.18

42.62

u/l

2.00

142

Excessive earwax

812

1.09

0.36

2.3

1.9

32.12

40.86

u/l

0.27

741

Pregnancy examination and test

1.29

0.36

3.1

1.3

9.51

35.82

u/l

0.77

malignant neoplasm of female genital organs

1.33

0.35

1.2

1.4

15.82

32.18

u/l

0.48

Other disorders of eyelid

550

1.11

0.35

1.6

2.1

16.68

45.86

u/l

3.63

504

Mental and behavioural disorders due to alcohol

655

0.90

0.33

1.7

1.9

106.53

30.95

u/l

0.83

597

Poor fetal growth

0.67

0.33

1.7

1.5

5.53

47.36

u/l

—

Asthma/COPD (KELA code 203)

134

834

1.07

0.32

1.6

1.9

22.54

40.39

u/l

2.02

119

759

Ectopic pregnancy

165

0.79

0.32

2.8

1.6

9.85

30.81

u/l

2.01

148

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

254

1.17

0.31

1.6

37.39

38.36

u/l

0.01

233

Appendicitis, broad definition

102

847

1.08

0.30

2.2

1.9

17.40

39.24

u/l

3.37

771

Diseases of appendix

103

853

1.08

0.30

2.2

1.9

17.30

39.22

u/l

3.43

776

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

1.30

0.30

2.4

1.6

29.60

63.60

u/l

—

Fall on same level involving ice and snow

787

0.91

0.30

1.5

2.0

28.37

38.66

u/l

0.68

717

Unspecified fall

670

0.91

0.30

1.3

1.9

47.70

37.08

u/l

0.17

614

Dermatophytosis, including avohilmo

852

0.92

0.29

1.6

1.9

32.39

39.64

u/l

0.18

780

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

575

1.10

0.29

1.6

1.8

47.51

32.21

u/l

0.28

519

Chronic periodontitis, complicated

763

1.09

0.29

1.9

2.0

41.18

41.39

u/l

0.00

696

Pre-eclampsia

184

0.81

0.28

1.7

1.5

10.87

45.38

u/l

1.68

164

Open wound of ankle and foot

119

0.76

0.27

1.1

1.8

42.08

42.03

u/l

—

113

Maternal care for other known or suspected fetal problems

122

0.82

0.27

1.5

1.3

23.40

29.40

u/l

0.15

108

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1.21

0.26

1.8

1.6

13.59

54.58

u/l

—

Open wound of forearm

113

1.24

0.26

1.4

1.7

15.58

43.39

u/l

1.09

107

Other noninflammatory disorders of vagina

1.23

0.25

2.7

1.7

11.49

41.88

u/l

—

Heterophoria

1.18

0.24

1.7

1.9

11.24

47.32

u/l

—

Superficial injury of abdomen, lower back and pelvis

170

1.18

0.24

1.9

13.60

47.36

u/l

1.48

160

Selective serotonin reuptake inhibitors

145

714

1.06

0.23

1.9

2.0

22.51

37.92

u/l

1.50

132

657

Alzheimer’s disease (Late onset), excluding more controls

117

1.17

0.22

2.4

2.3

13.49

49.55

u/l

2.19

109

Transient global amnesia

116

1.21

0.22

2.0

1.8

12.51

62.72

u/l

1.63

110

Pre-eclampsia or eclampsia

199

0.85

0.21

1.8

1.5

10.52

44.47

u/l

1.80

174

Injury of nerves at hip and thigh level

0.00

0.21

0.0

1.5

—

25.90

—

Right side

0.00

0.21

0.0

1.3

—

25.13

—

Factitial dermatitis

0.00

0.21

0.0

1.4

—

12.56

—

Severe visual impairment, binocular

0.00

0.21

0.0

1.6

—

14.35

—

Toxic effect of other gases, fumes and vapours

0.00

0.21

0.0

1.6

—

15.99

—

Carcinoma in situ of vagina

0.00

0.21

0.0

1.6

—

23.81

—

Lower leg

0.00

0.21

0.0

1.2

—

27.54

—

Contact with other specified venomous animals

0.00

0.21

0.0

1.5

—

28.05

—

Melanoma in situ of lower limb, including hip

0.00

0.21

0.0

1.3

—

26.54

—

Other and unspecified hypertrophic disorders of skin

0.00

0.21

0.0

1.3

—

25.20

—

Leiomyosarcoma

0.00

0.21

0.0

1.2

—

151.47

—

Vascular dementia (other)

0.00

0.21

0.0

1.5

—

27.53

—

Endometriosis of fallopian tube

0.00

0.21

0.0

2.3

—

145.67

—

Use of entacapone

0.00

0.21

0.0

1.6

—

24.01

—

Other corneal oedema

0.00

0.21

0.0

1.4

—

27.76

—

Pityriasis rosea

0.00

0.21

0.0

1.2

—

27.56

—

Fibrosarcoma, including Hilmo

0.00

0.21

0.0

1.3

—

21.73

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

0.00

0.21

0.0

1.4

—

28.11

—

Leiomyosarcoma, including Hilmo

0.00

0.21

0.0

1.2

—

151.47

—

Drug-induced obesity

0.00

0.21

0.0

1.5

—

21.80

—

Other and unspecified injuries of neck

0.00

0.21

0.0

1.2

—

17.78

—

Arnold-Chiari syndrome

0.00

0.21

0.0

1.4

—

24.30

—

Benign neoplasm: Rectum/anal canal icd-9

0.00

0.21

0.0

1.5

—

27.98

—

Synovial hypertrophy, not elsewhere classified

0.00

0.21

0.0

1.5

—

12.99

—

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

0.00

0.21

0.0

1.4

—

26.11

—

Other congenital malformations of nervous system

0.00

0.21

0.0

1.4

—

24.30

—

0.00

0.21

0.0

1.4

—

12.31

—

Cleft palate

0.00

0.21

0.0

1.2

—

22.83

—

Diseases caused by chlamydiae

0.00

0.21

0.0

2.1

—

22.90

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.21

0.0

1.2

—

11.99

—

Other diseases caused by chlamydiae

0.00

0.21

0.0

2.0

—

26.00

—

Convergence insufficiency and excess

0.00

0.21

0.0

1.4

—

13.72

—

Other disorders of breast and lactation associated with childbirth

0.00

0.21

0.0

1.3

—

19.86

—

Periapical abscess

596

0.92

0.21

2.0

1.9

22.76

37.57

u/l

1.08

541

Vaginal lichen planus

0.00

0.21

0.0

1.2

—

131.66

—

Benign neoplasm: Brain, unspecified

0.00

0.21

0.0

1.5

—

24.05

—

Rhinophyma

0.00

0.21

0.0

2.1

—

12.09

—

Carcinoma in situ of breast, lobular

0.00

0.21

0.0

1.3

—

132.72

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.21

0.0

1.5

—

18.42

—

Other benign neoplasm of uterus: Corpus uteri

0.00

0.21

0.0

1.5

—

98.99

—

Heberden's nodes [with arthropathy]

0.00

0.21

0.0

1.3

—

120.92

—

Protein-energy malnutrition of moderate and mild degree

0.00

0.21

0.0

1.8

—

26.22

—

Foreign body in genitourinary tract

0.00

0.21

0.0

1.2

—

14.00

—

Tic disorders

0.00

0.21

0.0

1.4

—

26.16

—

Injury of blood vessels at wrist and hand level

0.00

0.21

0.0

1.7

—

19.28

—

Melanocytic naevi of lip

0.00

0.21

0.0

1.5

—

23.68

—

Mental and behavioural disorders of puerperium, not classified elsewhere

0.00

0.21

0.0

1.5

—

121.51

—

Tic and related disorders

0.00

0.21

0.0

1.4

—

25.61

—

Malignant neoplasm of other and unspecified parts of tongue

0.00

0.21

0.0

1.5

—

120.18

—

Diseases caused by chlamydiae, including avohilmo

0.00

0.21

0.0

1.8

—

21.78

—

Other and unspecified mental retardation

0.00

0.20

0.0

1.4

—

23.16

—

Discontinuity and dislocation of ear ossicles

0.00

0.20

0.0

1.4

—

22.27

—

Alzheimer’s disease (undefined)

0.00

0.20

0.0

1.5

—

28.15

—

Other bursitis of knee

0.00

0.20

0.0

1.6

—

15.91

—

Other diseases caused by chlamydiae, including avohilmo

0.00

0.20

0.0

1.8

—

24.29

—

Endometriosis of intestine

0.00

0.20

0.0

2.0

—

115.14

—

Complications associated with artificial fertilization

0.00

0.20

0.0

2.0

—

16.44

—

Dislocation, sprain and strain of joints and ligaments of knee

676

0.94

0.19

1.5

2.0

13.80

39.37

u/l

3.85

615

Disorders of vestibular function (Vertigo)

601

1.07

0.19

1.9

25.26

40.48

u/l

0.77

553

Intrahepatic Cholestasis of Pregnancy (ICP)

1.13

0.18

1.8

1.7

15.45

64.77

u/l

—

Post-traumatic stress disorder

1.21

0.18

1.3

1.4

12.71

32.78

u/l

—

Postprocedural disorders of nervous system

1.17

0.17

3.6

1.7

13.20

54.25

u/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1.18

0.16

1.8

1.7

13.59

63.06

u/l

—

Dental pulpitis, including avohilmo

125

766

1.04

0.16

1.8

1.9

17.20

39.57

u/l

3.21

110

696

Hypertrophy of breast

162

0.86

0.16

2.0

1.6

131.76

40.51

u/l

0.34

146

Lesion of ulnar nerve

151

0.86

0.15

2.5

1.9

13.31

33.53

u/l

1.68

144

Endometriosis

197

0.91

0.15

1.4

1.6

41.73

28.77

u/l

0.26

176

Lumbar disc prolapse

592

1.05

0.14

1.9

16.51

36.79

u/l

3.02

536

Fracture at wrist and hand level

419

1.07

0.14

2.0

1.9

16.86

39.85

u/l

1.90

386

Polyp of the female genital tract

188

1.08

0.14

1.6

1.7

25.82

29.08

u/l

0.10

171

Other enthesopathy of foot (+metatarsalgia)

107

0.84

0.13

1.9

1.7

10.00

38.06

u/l

—

100

Abnormal findings in secretions and smears from cervix uteri vagina vulva

345

0.94

0.13

1.2

1.7

25.95

33.36

u/l

0.27

304

Biguanides

137

799

1.03

0.13

1.9

46.56

37.05

u/l

0.23

121

728

Thiazolidinediones

142

1.13

0.12

1.3

1.9

30.02

45.61

u/l

0.36

131

Burns and corrosions

148

0.88

0.12

2.3

1.8

17.48

32.60

u/l

0.64

139

Gonarthrosis,primary

132

770

1.03

0.12

2.0

56.94

37.94

u/l

0.41

124

704

Dentofacial anomalies [including malocclusion]

654

1.04

0.11

1.4

1.9

38.34

36.33

u/l

0.03

596

Sleep disorders (combined)

153

821

0.97

0.10

1.6

1.9

37.34

40.01

u/l

0.07

142

746

Endometriosis of ovary

157

0.90

0.10

1.6

1.7

68.84

29.07

u/l

—

140

Varicose veins

581

1.04

0.10

1.9

21.58

42.32

u/l

1.90

530

Any dementia, excluding more controls

347

0.95

0.10

2.4

2.0

15.63

36.22

u/l

3.02

330

Impingement syndrome of shoulder

280

0.93

0.10

2.7

1.9

16.96

33.35

u/l

1.43

258

Palmar fascial fibromatosis [Dupuytren]

187

0.91

0.10

1.6

1.9

16.50

28.27

u/l

0.64

173

Abdominal aortic aneurysm (AAA)

124

1.12

0.10

4.1

1.9

24.56

28.34

u/l

0.17

111

Internal derangement of knee

423

1.05

0.10

2.0

40.71

41.57

u/l

0.01

387

Other and unspecified glaucoma

1.15

0.09

1.9

1.8

14.79

74.26

u/l

—

Substance abuse

722

0.96

0.09

1.6

1.9

98.04

32.89

u/l

0.94

657

Pregnancy with abortive outcome

371

1.04

0.09

1.7

57.25

34.09

u/l

0.34

336

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

184

1.09

0.09

1.4

1.6

9.33

33.77

u/l

1.73

168

Other and unspecified mood [affective] disorders

1.11

0.09

1.0

1.6

11.17

32.37

u/l

—

Spondylolisthesis/Spondylolysis

194

1.08

0.09

1.6

1.9

92.40

27.47

u/l

0.37

177

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1.07

0.08

1.8

1.5

15.45

62.41

u/l

—

Mental and behavioural disorders due to psychoactive substance use

729

0.97

0.08

1.6

1.9

119.77

30.49

u/l

1.26

664

Superficial injury of shoulder and upper arm

136

1.10

0.08

2.1

1.9

24.44

49.45

u/l

—

129

Overexertion and strenuous or repetitive movements

107

1.12

0.08

1.3

1.8

18.99

55.91

u/l

0.90

102

Any dementia

381

0.96

0.07

2.2

1.9

14.72

44.93

u/l

3.54

362

Ganglion

215

1.07

0.07

2.0

1.9

85.30

26.96

u/l

0.36

196

Alzheimer’s disease, strict definition

272

0.95

0.07

2.3

1.9

13.50

45.23

u/l

2.59

256

Carcinoma in situ of breast, intraductal

0.82

0.07

1.4

1.7

20.69

75.72

u/l

—

Postpartum haemorrhage due to retained placenta

0.89

0.06

2.1

1.5

7.59

46.38

u/l

—

Substance abuse, excluding more controls

609

1.03

0.06

1.6

1.9

98.04

33.66

u/l

0.92

561

Metatarsalgia

101

0.89

0.06

1.9

1.7

10.00

39.75

u/l

—

Alzheimer’s disease (Late onset)

251

1.05

0.06

2.3

1.9

13.50

46.81

u/l

2.53

239

Glaucoma

687

1.03

0.06

1.9

2.0

18.77

41.98

u/l

2.74

633

Coxarthrosis, primary

713

1.02

0.06

1.7

2.0

50.37

40.04

u/l

0.21

657

Acute appendicitis, no complications

667

1.03

0.06

2.2

1.8

19.34

41.31

u/l

2.40

600

Superficial injury of thorax

172

0.93

0.06

2.0

1.9

71.06

46.65

u/l

0.19

163

Alzheimer’s disease (Atypical or mixed), excluding more controls

1.09

0.05

2.4

2.2

15.68

38.07

u/l

1.22

Tonsillectomy and adenotomy

400

0.97

0.04

1.5

1.6

37.72

31.86

u/l

0.15

361

Missing teeth due to accident, extraction or parodontitis

782

1.02

0.03

1.9

2.0

30.81

41.70

u/l

0.54

716

Alzheimer’s disease (Atypical or mixed)

126

0.94

0.02

2.4

1.8

15.68

42.44

u/l

1.07

119

Injuries to the neck

262

1.03

0.02

2.7

1.8

12.42

37.45

u/l

1.79

242

Exposure to other specified factors

107

927

0.99

0.02

1.8

1.9

45.94

36.72

u/l

0.22

843

Heartburn

103

1.07

0.02

1.1

1.8

7.77

48.41

u/l

—

Monoamine oxidase A inhibitors

127

0.94

0.01

1.2

2.0

13.61

45.16

u/l

1.14

119

Chronic diseases of tonsils and adenoids

612

1.01

0.01

1.6

2.0

27.62

42.82

u/l

0.82

547

Carpal tunnel syndrome

695

1.01

0.01

1.8

1.9

95.48

33.15

u/l

1.03

630

Appendectomy

764

1.01

0.00

2.1

1.8

17.90

37.23

u/l

2.79

691

Diseases of inner ear

711

1.01

0.00

1.8

2.0

24.00

40.11

u/l

1.00

650

Fracture of lower leg, including ankle

712

0.99

0.00

1.3

2.0

52.46

41.56

u/l

0.19

652

Other predominantly sexually transmitted diseases, not elsewhere classified

164

0.98

0.00

1.4

1.7

10.12

34.60

u/l

1.44

149

Complications predominantly related to the puerperium

226

1.02

0.00

1.7

1.6

18.93

38.28

u/l

0.75

198

Pneumonitis due to solids and liquids

102

0.98

0.00

1.4

1.9

87.27

52.99

u/l

—

Alzheimer disease, including avohilmo

363

0.99

0.00

2.1

2.0

13.62

45.98

u/l

3.74

345

Disorders of psychological development

0.97

0.00

1.7

14.48

35.36

u/l

—

False labour

155

1.00

0.00

1.3

1.4

18.18

36.68

u/l

0.72

138

Unspecified mental disorder

475

0.99

0.00

1.5

1.8

16.72

34.44

u/l

1.66

429

Excessive attrition of teeth

756

0.99

0.00

2.0

1.9

45.73

36.96

u/l

0.12

679

Burns and corrosions of external body surface, specified by site

117

1.03

0.00

2.3

1.7

18.33

38.13

u/l

0.70

111

Presbycusis

176

1.01

0.00

2.1

1.8

19.89

52.78

u/l

1.38

163

Erectile dysfunction

102

0.98

0.00

2.0

2.2

11.28

22.60

u/l

—

Carcinoma in situ of skin

111

0.99

0.00

1.5

1.8

34.97

62.24

u/l

0.41

105

Alzheimer disease

316

1.00

0.00

2.3

1.9

14.70

44.29

u/l

2.89

299

Persons encountering health services in circumstances related to reproduction

437

1.00

0.00

1.9

1.8

14.49

37.77

u/l

2.58

401

Coxarthrosis, primary, with hip surgery

617

1.01

0.00

1.8

2.0

34.54

38.73

u/l

0.18

570

Other congenital malformations of heart

0.00

0.0

1.3

—

23.29

—

Enterobiasis

0.00

0.0

1.3

—

31.84

—

Cholinergic urticaria

0.00

0.0

1.3

—

8.66

—

Abnormal pulmonary venous return

0.00

0.0

1.2

—

35.72

—

Haemorrhagic and haematological disorders of fetus and newborn

0.00

0.0

2.0

—

22.80

—

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

0.00

0.0

2.4

—

33.22

—

Other sexually transmitted chlamydial diseases

0.94

0.00

1.0

1.8

7.88

14.29

u/l

—

Benign neoplasm: Lower jaw bone

0.00

0.0

1.4

—

30.84

—

Unspecified transport accident

0.00

0.0

1.4

—

9.05

—

0.00

0.0

1.3

—

10.54

—

Vascular dementia (sudden onset)

0.00

0.0

1.6

—

31.30

—

Unspecified multiple injuries

0.00

0.0

1.0

—

18.94

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.0

1.5

—

39.17

—

Cleft lip

0.00

0.0

1.2

—

9.16

—

Malaria

0.00

0.0

1.4

—

24.11

—

Congenital malformations of oesophagus, including avohilmo

0.00

0.0

1.3

—

29.61

—

Ankylosis of joint

0.00

0.0

1.6

—

17.52

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.0

1.4

—

8.90

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.00

0.0

1.0

—

34.39

—

ILD medications: acetylcysteine

0.00

0.0

1.6

—

12.91

—

Brain astrocytoma, helper endpoint

0.00

0.0

1.3

—

10.96

—

Other specified/unspecified diseases of inner ear

0.00

0.0

1.4

—

15.96

—

Acne varioliformis

0.00

0.0

1.0

—

46.34

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

0.0

1.3

—

16.97

—

Other degenerative disorders of eyelid and periocular area

0.00

0.0

1.7

—

16.63

—

Other and unspecified disorders of adult personality and behaviour

0.00

0.0

1.2

—

8.30

—

Pituitary-dependent Cushing's disease

0.00

0.0

1.3

—

13.97

—

Postinfectious hypothyroidism

0.00

0.0

1.3

—

30.74

—

Idiopathic hypoparathyroidism

0.00

0.0

1.4

—

43.12

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.0

1.2

—

43.60

—

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

0.0

1.2

—

33.76

—

Congenital malformations of oesophagus

0.00

0.0

1.2

—

5.58

—

Chromophobe cell carcinoma of kidney

0.00

0.0

1.3

—

32.28

—

Other parasitologically confirmed or unspecified malaria

0.00

0.0

1.2

—

29.93

—

Scarlet fever, including avohilmo

0.00

0.0

1.1

—

18.40

—

Other infestations

0.00

0.0

1.3

—

37.35

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

0.00

0.0

1.4

—

7.02

—

Congenital malformations of posterior segment of eye

0.00

0.0

1.2

—

18.12

—

Lichenoid drug reaction

0.00

-0.00

0.0

1.3

—

37.77

—

Plasmodium falciparum malaria

0.00

-0.00

0.0

1.6

—

8.26

—

Other and unspecified cicatricial alopecia

0.00

-0.00

0.0

1.3

—

29.28

—

Other chromosome abnormalities, not elsewhere classified

0.00

-0.00

0.0

1.0

—

8.84

—

Tympanosclerosis

0.00

-0.00

0.0

1.2

—

39.27

—

Erythema in diseases classified elsewhere

0.00

-0.00

0.0

1.5

—

29.05

—

Disorders of sphingolipid metabolism and other lipid storage disorders

0.00

-0.00

0.0

1.6

—

26.19

—

Endometriosis in cutaneous scar

0.00

-0.00

0.0

3.4

—

10.00

—

Other specified and unspecified disorders of iris and ciliary body

0.00

-0.00

0.0

1.3

—

31.37

—

Bicornuate uterus

0.00

-0.00

0.0

1.1

—

27.50

—

Other and unspecified localized connective tissue disorders

0.00

-0.00

0.0

1.3

—

29.85

—

Sunburn

0.00

-0.00

0.0

1.6

—

7.74

—

Degenerative myopia

0.00

-0.00

0.0

1.5

—

14.76

—

Other fibroblastic disorders

0.00

-0.00

0.0

1.6

—

11.74

—

Other infective (teno)synovitis

0.00

-0.00

0.0

1.2

—

9.82

—

Calcific tendinitis

0.00

-0.00

0.0

1.3

—

9.16

—

Other specified acquired deformities of limbs

0.00

-0.00

0.0

1.4

—

16.81

—

Use of fingolimod

0.00

-0.00

0.0

1.1

—

14.20

—

Juvenile cataract

0.00

-0.00

0.0

1.2

—

9.63

—

Other changes in lacrimal passages

0.00

-0.00

0.0

1.4

—

17.42

—

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

0.00

-0.00

0.0

1.7

—

27.59

—

Food allergy

0.00

-0.00

0.0

1.2

—

36.00

—

Transient synovitis

0.00

-0.00

0.0

1.2

—

12.88

—

Valgus deformity, not elsewhere classified

0.00

-0.00

0.0

1.2

—

117.37

—

Use of dimethyl fumarate

0.00

-0.00

0.0

1.2

—

16.85

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

0.00

-0.00

0.0

1.2

—

39.27

—

Primary amenorrhea

0.00

-0.00

0.0

1.2

—

20.17

—

Arteriovenous malformation of peripheral vessels

0.00

-0.00

0.0

1.2

—

24.27

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.00

-0.00

0.0

1.5

—

16.62

—

Benign muscular dystrophy (Becker)

0.00

-0.00

0.0

1.2

—

13.12

—

Congenital malformations of cardiac chambers and connections

0.00

-0.00

0.0

1.2

—

14.42

—

Rapidly progressive nephritic syndrome

0.00

-0.00

0.0

1.3

—

8.37

—

Senile degeneration of the brain, not elsewhere classified

0.00

-0.00

0.0

1.3

—

38.37

—

Other specified and unspecified personality disorders

0.99

-0.00

1.1

1.9

171.96

29.93

u/l

—

Mucinous and mucinous cystic tumor, including Hilmo

0.00

-0.00

0.0

1.7

—

216.06

—

Hydatidiform mole

0.00

-0.00

0.0

1.3

—

29.29

—

Mental and behavioural disorders due to hallucinogens

0.00

-0.00

0.0

1.4

—

15.91

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

0.00

-0.00

0.0

1.4

—

22.30

—

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

0.00

-0.00

0.0

1.4

—

34.60

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

0.00

-0.00

0.0

1.5

—

39.17

—

Psoas tendinitis

0.00

-0.00

0.0

1.7

—

9.67

—

Congenital cataract

0.00

-0.00

0.0

1.4

—

17.64

—

Congenital lens malformations

0.00

-0.00

0.0

1.4

—

17.64

—

Corneal pigmentations and deposits

0.00

-0.00

0.0

1.1

—

34.93

—

Marasmic kwashiorkor

0.00

-0.00

0.0

1.3

—

26.77

—

Esophageal diverticulum (pouch), including avohilmo

0.00

-0.00

0.0

1.3

—

36.80

—

Mental and behavioural disorders associated with the puerperium

0.00

-0.00

0.0

2.2

—

21.29

—

Congenital malformations of nose, including avohilmo

0.00

-0.00

0.0

1.4

—

8.02

—

Down's syndrome

0.00

-0.00

0.0

1.2

—

10.54

—

Abnormal reflex

0.00

-0.00

0.0

1.3

—

17.41

—

Burn and corrosion, body region unspecified

0.00

-0.00

0.0

1.6

—

9.61

—

L02BX Other hormone antagonists and related agents

0.95

-0.00

1.0

2.2

142.39

21.21

u/l

—

Henoch-Schönlein purpura nephritis (HSPN)

0.00

-0.00

0.0

1.2

—

34.84

—

Thyrotoxicosis factitia

0.00

-0.00

0.0

1.2

—

37.35

—

Other hyperalimentation

0.00

-0.00

0.0

1.6

—

17.98

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.00

-0.00

0.0

1.3

—

15.74

—

Symptoms and signs involving appearance and behaviour

0.00

-0.00

0.0

1.5

—

6.57

—

Alkalosis

0.00

-0.00

0.0

1.5

—

29.05

—

Drug-induced dystonia

0.00

-0.00

0.0

1.2

—

33.42

—

Abnormalities of ear ossicles

0.00

-0.00

0.0

1.4

—

6.94

—

Apocrine sweat disorders, other sweat gland disorders

0.00

-0.00

0.0

1.4

—

32.94

—

0.00

-0.00

0.0

1.2

—

15.10

—

Injury of blood vessels at neck level

0.00

-0.00

0.0

1.4

—

23.23

—

Other hypertrichosis

0.00

-0.00

0.0

1.0

—

43.62

—

Adrenogenital disorders

0.00

-0.00

0.0

1.4

—

33.73

—

Drug-induced gout

0.00

-0.00

0.0

1.9

—

15.11

—

Other sideroblastic anaemias

0.00

-0.00

0.0

1.6

—

18.28

—

Benign neoplasm: Vertebral column

0.00

-0.00

0.0

1.2

—

30.80

—

Effects of other deprivation

0.00

-0.00

0.0

1.4

—

23.44

—

Focal brain injury

0.97

-0.00

2.0

1.9

65.62

29.00

u/l

—

Diastasis of muscle

0.00

-0.00

0.0

1.4

—

10.67

—

Benign neoplasm: Urethra

0.00

-0.00

0.0

1.4

—

44.20

—

Injury of blood vessels at hip and thigh level

0.00

-0.00

0.0

1.3

—

28.22

—

Other specified transport accidents

0.00

-0.00

0.0

1.3

—

10.60

—

Acrodermatitis continua

0.00

-0.00

0.0

1.5

—

16.77

—

Other effects of reduced temperature

0.00

-0.00

0.0

1.2

—

7.76

—

Benign neoplasm: Carotid body

0.00

-0.00

0.0

1.2

—

35.72

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

-0.00

0.0

1.3

—

33.59

—

Carcinoma in situ of endometrium

0.00

-0.00

0.0

1.2

—

27.32

—

Contact urticaria

0.00

-0.00

0.0

1.7

—

10.32

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

-0.00

0.0

1.4

—

7.02

—

Scarlet fever

0.00

-0.00

0.0

1.1

—

18.40

—

Fall involving playground equipment

0.00

-0.00

0.0

1.3

—

28.17

—

Whooping cough

0.00

-0.00

0.0

1.2

—

19.34

—

Intentional self-harm by jumping from a high place

0.00

-0.00

0.0

1.2

—

8.72

—

Alzheimer’s disease (undefined), excluding more controls

0.00

-0.00

0.0

1.3

—

133.53

—

Failure in dosage during surgical and medical care

0.00

-0.00

0.0

1.2

—

42.62

—

Benign neoplasm: Extrahepatic bile ducts

0.00

-0.00

0.0

1.3

—

30.15

—

Foreign object accidentally left in body during surgical and medical care

0.00

-0.00

0.0

1.4

—

44.52

—

Chloasma

0.00

-0.00

0.0

1.3

—

34.01

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.4

—

34.14

—

Cyst of spleen

0.00

-0.00

0.0

1.2

—

18.36

—

Accessory breast

0.00

-0.00

0.0

1.2

—

28.75

—

Intentional self-harm by smoke, fire and flames

0.00

-0.00

0.0

1.4

—

9.34

—

Congenital ptosis, including avohilmo

0.00

-0.00

0.0

1.3

—

19.52

—

Nonadministration of surgical and medical care

0.00

-0.00

0.0

1.4

—

26.47

—

Hereditary nephropathy, not elsewhere classified

0.00

-0.00

0.0

1.7

—

38.38

—

Sequelae of intentional self-harm, assault and events of undetermined intent

0.00

-0.00

0.0

1.3

—

10.81

—

Familial erythrocytosis

0.00

-0.00

0.0

1.4

—

10.47

—

Excessive vomiting in pregnancy

0.94

-0.00

1.0

1.6

8.72

67.99

u/l

—

Left side

0.00

-0.00

0.0

1.6

—

30.61

—

Hand

0.00

-0.00

0.0

1.2

—

15.64

—

Tic and related disorders

0.00

-0.00

0.0

1.4

—

16.40

—

Prophylactic surgery

0.00

-0.00

0.0

3.2

—

37.88

—

Neuroendocrine tumor and carcinoma of rectum

0.00

-0.00

0.0

1.4

—

25.51

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.2

—

20.72

—

Other congenital malformations, not elsewhere classified

0.00

-0.00

0.0

1.1

—

19.96

—

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

0.00

-0.00

0.0

1.4

—

32.30

—

Mucinous and mucinous cystic tumor of rectum

0.00

-0.00

0.0

1.4

—

5.86

—

Drug-induced thyroiditis

0.00

-0.00

0.0

1.6

—

17.46

—

Endometroid carcinoma of ovary

0.00

-0.00

0.0

1.4

—

34.68

—

Mucinous and mucinous cystic tumor

0.00

-0.00

0.0

2.0

—

37.88

—

Hypertrophy of (infrapatellar) fat pad

0.00

-0.00

0.0

1.6

—

10.71

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

-0.00

0.0

1.3

—

16.18

—

Endometroid carcinoma of ovary, including Hilmo

0.00

-0.00

0.0

1.3

—

189.42

—

Fractures involving multiple body regions

0.00

-0.00

0.0

1.4

—

16.53

—

Hereditary factor VIII deficiency

0.00

-0.00

0.0

1.7

—

17.82

—

Acquired pure red cell aplasia [erythroblastopenia]

0.00

-0.00

0.0

1.7

—

8.28

—

Malignant neoplasm of gallbladder

0.00

-0.00

0.0

1.4

—

33.50

—

Right ventricular outflow tract obstruction

0.00

-0.00

0.0

1.0

—

45.04

—

Systemic disorders of connective tissue in diseases classified elsewhere

0.00

-0.00

0.0

1.6

—

17.98

—

Malignant neoplasm of gallbladder, including Hilmo

0.00

-0.00

0.0

1.3

—

29.75

—

Other and unspecified atrophic disorders of skin

0.00

-0.00

0.0

1.3

—

29.14

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.2

—

42.42

—

Carcinoma in situ of breast

0.00

-0.00

0.0

1.1

—

32.79

—

Fibrosarcoma

0.00

-0.00

0.0

1.3

—

23.54

—

Malignant neoplasm of floor of mouth, including Hilmo

0.00

-0.00

0.0

1.3

—

28.22

—

Acquired clawhand, clubhand, clawfoot and clubfoot

0.00

-0.00

0.0

1.1

—

16.69

—

Trichomoniasis

0.00

-0.00

0.0

1.4

—

275.30

—

Atrioventricular septal defect

0.00

-0.00

0.0

1.1

—

36.81

—

Acanthosis nigricans

0.00

-0.00

0.0

1.8

—

35.44

—

Defect, injury or illness of lumbar spine

0.00

-0.00

0.0

1.2

—

10.34

—

Brain astrocytoma

0.00

-0.00

0.0

1.3

—

12.12

—

Histrionic personality disorder

0.00

-0.00

0.0

1.2

—

30.03

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

-0.00

0.0

1.0

—

17.06

—

Trichomoniasis, including avohilmo

0.00

-0.00

0.0

1.4

—

275.30

—

Non-seminoma of testis, including Hilmo

0.00

-0.00

0.0

1.2

—

11.50

—

Brain astrocytoma, including Hilmo

0.00

-0.00

0.0

1.3

—

12.12

—

Plasmodium falciparum malaria, including avohilmo

0.00

-0.00

0.0

1.5

—

7.90

—

Squamous cell neoplasms and carcinoma of cervix

0.00

-0.00

0.0

1.3

—

247.57

—

Other bursitis, not elsewhere classified

0.00

-0.00

0.0

1.4

—

12.80

—

Other helminthiases, including avohilmo

0.00

-0.00

0.0

1.2

—

15.64

—

Familial benign pemphigus (Hailey-Hailey disease)

0.00

-0.00

0.0

1.5

—

40.53

—

Post-traumatic hydrocephalus, unspecified

0.00

-0.00

0.0

1.8

—

33.84

—

Complex cardiac defects

0.00

-0.00

0.0

1.1

—

32.31

—

Maxillary prognathism

0.00

-0.00

0.0

1.0

—

9.34

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.00

-0.00

0.0

1.1

—

12.74

—

Impaction of intestines

0.00

-0.00

0.0

1.4

—

15.71

—

Acne keloid

0.00

-0.00

0.0

1.3

—

15.74

—

Acquired keratosis [keratoderma] palmaris et plantaris

0.00

-0.00

0.0

1.4

—

28.63

—

Toxic erythema

0.00

-0.00

0.0

1.1

—

16.64

—

Ulcer of oesophagus, drug-induced

0.00

-0.00

0.0

1.4

—

16.82

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

1.3

—

27.40

—

Other deformity of hallux (acquired)

0.00

-0.00

0.0

1.3

—

14.29

—

Unspecified maternal hypertension

0.00

-0.00

0.0

1.0

—

12.40

—

Hypertension, portal

0.00

-0.00

0.0

1.2

—

37.18

—

Obstetric embolism

0.00

-0.00

0.0

1.3

—

31.59

—

Alopecia universalis

0.00

-0.00

0.0

1.2

—

28.70

—

Poikiloderma of Civatte

0.00

-0.00

0.0

1.2

—

6.44

—

Transient retinal artery occlusion

0.00

-0.00

0.0

1.8

—

31.13

—

Other/unspecified mastoiditis and related conditions

0.00

-0.00

0.0

1.3

—

37.97

—

Gender identity disorders

0.00

-0.00

0.0

1.2

—

19.36

—

Chronic myringitis

0.00

-0.00

0.0

1.0

—

16.17

—

Contact with hypodermic needle

0.00

-0.00

0.0

1.1

—

13.48

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Thymidine kinase [Enzymatic activity/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS